| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of synapse | 6.56e-07 | 42 | 149 | 6 | GO:0098918 | |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 9.43e-07 | 11 | 149 | 4 | GO:0098973 | |
| GeneOntologyMolecularFunction | RNA polymerase III general transcription initiation factor binding | 1.62e-06 | 4 | 149 | 3 | GO:0001025 | |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 3.70e-06 | 32 | 149 | 5 | GO:0099186 | |
| GeneOntologyMolecularFunction | protein-cysteine methyltransferase activity | 5.53e-05 | 2 | 149 | 2 | GO:0106363 | |
| GeneOntologyBiologicalProcess | muscle cell development | 1.62e-05 | 259 | 146 | 10 | GO:0055001 | |
| GeneOntologyBiologicalProcess | striated muscle cell differentiation | FLNC MYH7 ZMPSTE24 YBX1 RBM10 FHOD3 XK NR3C1 LMOD3 NKX2-5 ALPK2 CDON | 2.29e-05 | 391 | 146 | 12 | GO:0051146 |
| GeneOntologyBiologicalProcess | cardiac cell development | 4.34e-05 | 132 | 146 | 7 | GO:0055006 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | FLNC MYH7 ARHGEF19 ARHGEF5 POTEF WASF3 RICTOR FHOD3 POTEE CRACD LMOD3 PIK3R2 TLR2 NKX2-5 ARHGAP28 POTEI POTEJ | 5.54e-05 | 803 | 146 | 17 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament polymerization | 6.38e-05 | 190 | 146 | 8 | GO:0030041 | |
| GeneOntologyBiologicalProcess | postsynaptic actin cytoskeleton organization | 6.53e-05 | 31 | 146 | 4 | GO:0098974 | |
| GeneOntologyBiologicalProcess | actin filament-based process | CACNA1C FLNC MYH7 ARHGEF19 ARHGEF5 POTEF WASF3 RICTOR FHOD3 POTEE CRACD LMOD3 PIK3R2 TLR2 NKX2-5 ARHGAP28 POTEI POTEJ | 8.12e-05 | 912 | 146 | 18 | GO:0030029 |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 9.74e-05 | 65 | 146 | 5 | GO:0045815 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | FLNC MYH7 ZMPSTE24 YBX1 RBM10 FHOD3 XK NR3C1 LMOD3 SUPT6H NKX2-5 ALPK2 CDON | 1.06e-04 | 531 | 146 | 13 | GO:0042692 |
| GeneOntologyBiologicalProcess | postsynaptic cytoskeleton organization | 1.06e-04 | 35 | 146 | 4 | GO:0099188 | |
| GeneOntologyBiologicalProcess | positive regulation of gene expression, epigenetic | 1.21e-04 | 68 | 146 | 5 | GO:0141137 | |
| GeneOntologyBiologicalProcess | muscle structure development | FLNC MYH7 ZMPSTE24 YBX1 RBM10 FHOD3 XK NR3C1 LMOD3 FXR1 PAXBP1 SUPT6H JAG1 GPCPD1 NKX2-5 ALPK2 CDON | 1.24e-04 | 858 | 146 | 17 | GO:0061061 |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 1.25e-04 | 156 | 146 | 7 | GO:0030833 | |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse, modulating synaptic transmission | 1.49e-04 | 3 | 146 | 2 | GO:0099577 | |
| GeneOntologyBiologicalProcess | regulation of translation at presynapse | 1.49e-04 | 3 | 146 | 2 | GO:0140244 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to non-antigenic stimulus | 1.49e-04 | 3 | 146 | 2 | GO:0002879 | |
| GeneOntologyBiologicalProcess | regulation of protein K48-linked deubiquitination | 1.49e-04 | 3 | 146 | 2 | GO:1903093 | |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | 1.87e-04 | 222 | 146 | 8 | GO:0008154 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | ABCA3 STXBP5 ARHGEF5 RICTOR FHOD3 CRACD LMOD3 PIK3R2 TLR2 EIF4G1 ARHGAP28 AJUBA | 1.92e-04 | 489 | 146 | 12 | GO:0043254 |
| GeneOntologyBiologicalProcess | regulation of cellular component size | SEMA4D RICTOR FHOD3 XK CRACD LMOD3 PIK3R2 TLR2 ANAPC2 ARHGAP28 GOLGA4 | 2.31e-04 | 426 | 146 | 11 | GO:0032535 |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 2.34e-04 | 122 | 146 | 6 | GO:0055013 | |
| GeneOntologyBiologicalProcess | DNA-templated transcription initiation | 2.45e-04 | 231 | 146 | 8 | GO:0006352 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | TET2 ZMPSTE24 GATAD2A ZNFX1 CHD3 NR3C1 BCOR BAZ1A SUPT6H RLIM RNF20 DDX23 KMT2A PADI2 DNMT3A | 2.52e-04 | 741 | 146 | 15 | GO:0006338 |
| GeneOntologyBiologicalProcess | protein deubiquitination | 2.67e-04 | 125 | 146 | 6 | GO:0016579 | |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 2.71e-04 | 177 | 146 | 7 | GO:0008064 | |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | 2.93e-04 | 300 | 146 | 9 | GO:0110053 | |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | CACNA1C ARHGEF19 ARHGEF5 WASF3 RICTOR FHOD3 CRACD LMOD3 PIK3R2 TLR2 ARHGAP28 | 2.93e-04 | 438 | 146 | 11 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of acute inflammatory response to non-antigenic stimulus | 2.96e-04 | 4 | 146 | 2 | GO:0002877 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 3.00e-04 | 180 | 146 | 7 | GO:0030832 | |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 3.09e-04 | 239 | 146 | 8 | GO:0031032 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 3.65e-04 | 86 | 146 | 5 | GO:0030239 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 4.06e-04 | 249 | 146 | 8 | GO:0008016 | |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | ARHGEF19 ARHGEF5 WASF3 RICTOR FHOD3 CRACD LMOD3 PIK3R2 TLR2 ARHGAP28 | 4.18e-04 | 384 | 146 | 10 | GO:0032956 |
| GeneOntologyBiologicalProcess | striated muscle cell development | 4.27e-04 | 89 | 146 | 5 | GO:0055002 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | CACNA1C SEMA4D RICTOR FHOD3 XK CHGA CRACD LMOD3 PIK3R2 TLR2 ANAPC2 ARHGAP28 GOLGA4 | 4.60e-04 | 618 | 146 | 13 | GO:0090066 |
| GeneOntologyBiologicalProcess | viral translational termination-reinitiation | 4.91e-04 | 5 | 146 | 2 | GO:0075525 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to non-antigenic stimulus | 4.91e-04 | 5 | 146 | 2 | GO:0002525 | |
| GeneOntologyBiologicalProcess | protein modification by small protein removal | 5.68e-04 | 144 | 146 | 6 | GO:0070646 | |
| GeneOntologyBiologicalProcess | epigenetic regulation of gene expression | 5.85e-04 | 330 | 146 | 9 | GO:0040029 | |
| GeneOntologyCellularComponent | cochlear hair cell ribbon synapse | 6.71e-06 | 6 | 147 | 3 | GO:0098683 | |
| GeneOntologyCellularComponent | cytoplasmic stress granule | 6.01e-05 | 96 | 147 | 6 | GO:0010494 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 7.24e-05 | 32 | 147 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 7.24e-05 | 32 | 147 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | cytoplasmic ribonucleoprotein granule | 1.24e-04 | 269 | 147 | 9 | GO:0036464 | |
| GeneOntologyCellularComponent | ribonucleoprotein granule | 2.02e-04 | 287 | 147 | 9 | GO:0035770 | |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 2.80e-04 | 45 | 147 | 4 | GO:1902562 | |
| GeneOntologyCellularComponent | actin cytoskeleton | FLNC MYH7 ARHGEF5 POTEF FHOD3 MYL12A POTEE LMOD3 TRMT10A MARK2 POTEI POTEJ | 7.85e-04 | 576 | 147 | 12 | GO:0015629 |
| HumanPheno | Fatiguable weakness of proximal limb muscles | 1.01e-06 | 22 | 45 | 5 | HP:0030200 | |
| HumanPheno | Stroke | TET2 FLNC ZMPSTE24 CDH23 FHOD3 NR3C1 USP8 MLXIPL JAG1 NKX2-5 | 4.01e-06 | 189 | 45 | 10 | HP:0001297 |
| HumanPheno | Optic nerve compression | 6.76e-06 | 15 | 45 | 4 | HP:0007807 | |
| HumanPheno | Dorsocervical fat pad | 1.16e-05 | 17 | 45 | 4 | HP:0025383 | |
| HumanPheno | Supraventricular arrhythmia | 1.77e-05 | 134 | 45 | 8 | HP:0005115 | |
| HumanPheno | Abnormal cerebral vascular morphology | TET2 FLNC MYH7 ZMPSTE24 RBM10 CDH23 FHOD3 NR3C1 USP8 MLXIPL JAG1 NKX2-5 DNMT3A | 1.83e-05 | 388 | 45 | 13 | HP:0100659 |
| HumanPheno | Capillary fragility | 2.20e-05 | 7 | 45 | 3 | HP:0025017 | |
| HumanPheno | Tachycardia | 3.07e-05 | 189 | 45 | 9 | HP:0001649 | |
| HumanPheno | Abnormal eosinophil morphology | 3.40e-05 | 72 | 45 | 6 | HP:0001879 | |
| HumanPheno | Fatigable weakness of skeletal muscles | 4.02e-05 | 45 | 45 | 5 | HP:0030197 | |
| HumanPheno | Ventricular arrhythmia | 4.55e-05 | 249 | 45 | 10 | HP:0004308 | |
| HumanPheno | Flushing | 4.99e-05 | 47 | 45 | 5 | HP:0031284 | |
| HumanPheno | Decreased eosinophil count | 5.22e-05 | 9 | 45 | 3 | HP:0031891 | |
| HumanPheno | Intra-oral hyperpigmentation | 5.22e-05 | 9 | 45 | 3 | HP:0010284 | |
| HumanPheno | Abnormal cardiac septum morphology | CACNA1C AARS1 MYH7 ZMPSTE24 RBM10 TCIRG1 PEX14 FHOD3 CHD3 BCOR LETM1 MLXIPL CCDC47 PIK3R2 JAG1 KMT2A NKX2-5 DNMT3A | 5.69e-05 | 787 | 45 | 18 | HP:0001671 |
| HumanPheno | Abnormal granulocyte morphology | TET2 SEMA4D AARS1 CDH23 TCIRG1 ZNFX1 NR3C1 BCOR MDM4 USP8 SLC39A7 | 6.83e-05 | 317 | 45 | 11 | HP:0001911 |
| HumanPheno | Supraventricular tachycardia | 7.30e-05 | 120 | 45 | 7 | HP:0004755 | |
| HumanPheno | Abnormal capillary physiology | 7.41e-05 | 10 | 45 | 3 | HP:0025018 | |
| HumanPheno | Cranial nerve compression | 7.44e-05 | 51 | 45 | 5 | HP:0001293 | |
| HumanPheno | Ventricular septal defect | CACNA1C AARS1 MYH7 TCIRG1 PEX14 CHD3 BCOR LETM1 MLXIPL CCDC47 PIK3R2 JAG1 NKX2-5 DNMT3A | 7.57e-05 | 510 | 45 | 14 | HP:0001629 |
| HumanPheno | Abnormality of subcutaneous fat tissue | 9.34e-05 | 86 | 45 | 6 | HP:0001001 | |
| HumanPheno | Abnormal ventricular septum morphology | CACNA1C AARS1 MYH7 TCIRG1 PEX14 CHD3 BCOR LETM1 MLXIPL CCDC47 PIK3R2 JAG1 NKX2-5 DNMT3A | 9.57e-05 | 521 | 45 | 14 | HP:0010438 |
| HumanPheno | Abnormal granulocyte count | 9.64e-05 | 272 | 45 | 10 | HP:0032309 | |
| HumanPheno | Atrial fibrillation | 1.06e-04 | 88 | 45 | 6 | HP:0005110 | |
| HumanPheno | Arterial stenosis | 1.20e-04 | 225 | 45 | 9 | HP:0100545 | |
| HumanPheno | Abnormalities of the peripheral arteries | 1.24e-04 | 226 | 45 | 9 | HP:0005114 | |
| HumanPheno | Pituitary corticotropic cell adenoma | 1.34e-04 | 12 | 45 | 3 | HP:0008291 | |
| HumanPheno | Ecchymosis | 1.39e-04 | 58 | 45 | 5 | HP:0031364 | |
| HumanPheno | Atrial arrhythmia | 1.45e-04 | 93 | 45 | 6 | HP:0001692 | |
| HumanPheno | Abnormal mitral valve physiology | 1.46e-04 | 180 | 45 | 8 | HP:0031481 | |
| HumanPheno | Abnormal myeloid leukocyte morphology | TET2 SEMA4D AARS1 CDH23 TCIRG1 ZNFX1 NR3C1 BCOR MDM4 USP8 SLC39A7 | 1.51e-04 | 346 | 45 | 11 | HP:0010974 |
| HumanPheno | Abnormal cardiac atrium morphology | CACNA1C FLNC MYH7 ZMPSTE24 RBM10 FHOD3 CHD3 BCOR LETM1 MLXIPL PIK3R2 JAG1 KMT2A NKX2-5 DNMT3A | 1.57e-04 | 617 | 45 | 15 | HP:0005120 |
| HumanPheno | Abnormality of hair texture | CACNA1C AARS1 ZMPSTE24 CDH23 TCIRG1 NR3C1 USP8 TRMT10A CCDC47 RLIM | 1.65e-04 | 290 | 45 | 10 | HP:0010719 |
| HumanPheno | Abnormal cardiac ventricle morphology | CACNA1C FLNC AARS1 MYH7 ZMPSTE24 TCIRG1 PEX14 FHOD3 CHD3 BCOR LETM1 MLXIPL CCDC47 PIK3R2 JAG1 NKX2-5 DNMT3A | 1.88e-04 | 780 | 45 | 17 | HP:0001713 |
| HumanPheno | Increased circulating ACTH level | 2.19e-04 | 14 | 45 | 3 | HP:0003154 | |
| HumanPheno | Plethora | 2.19e-04 | 14 | 45 | 3 | HP:0001050 | |
| HumanPheno | Abnormal eosinophil count | 2.56e-04 | 66 | 45 | 5 | HP:0020064 | |
| HumanPheno | Large sella turcica | 2.72e-04 | 15 | 45 | 3 | HP:0002690 | |
| HumanPheno | Moon facies | 2.72e-04 | 15 | 45 | 3 | HP:0500011 | |
| HumanPheno | Abnormal mitral valve morphology | 3.29e-04 | 257 | 45 | 9 | HP:0001633 | |
| HumanPheno | Paradoxical increased cortisol secretion on dexamethasone suppression test | 3.33e-04 | 16 | 45 | 3 | HP:0003466 | |
| HumanPheno | Increased urinary cortisol level | 3.33e-04 | 16 | 45 | 3 | HP:0012030 | |
| HumanPheno | Myocardial infarction | 3.81e-04 | 111 | 45 | 6 | HP:0001658 | |
| HumanPheno | Acute coronary syndrome | 3.81e-04 | 111 | 45 | 6 | HP:0033678 | |
| HumanPheno | Livedo reticularis | 4.79e-04 | 18 | 45 | 3 | HP:0033505 | |
| HumanPheno | Psychotic episodes | 4.79e-04 | 18 | 45 | 3 | HP:0000725 | |
| HumanPheno | Mitral regurgitation | 4.91e-04 | 163 | 45 | 7 | HP:0001653 | |
| HumanPheno | Abnormal atrioventricular valve physiology | 4.93e-04 | 215 | 45 | 8 | HP:0031650 | |
| HumanPheno | Coronary artery atherosclerosis | 5.49e-04 | 166 | 45 | 7 | HP:0001677 | |
| HumanPheno | Atrial septal defect | CACNA1C MYH7 ZMPSTE24 RBM10 CHD3 BCOR LETM1 MLXIPL PIK3R2 JAG1 KMT2A NKX2-5 DNMT3A | 5.58e-04 | 541 | 45 | 13 | HP:0001631 |
| HumanPheno | Abnormality of the atrial septum | CACNA1C MYH7 ZMPSTE24 RBM10 CHD3 BCOR LETM1 MLXIPL PIK3R2 JAG1 KMT2A NKX2-5 DNMT3A | 5.58e-04 | 541 | 45 | 13 | HP:0001630 |
| HumanPheno | Abnormal urine hormone level | 5.66e-04 | 19 | 45 | 3 | HP:0012029 | |
| HumanPheno | Abnormal heart valve physiology | FLNC MYH7 ABCA3 ZMPSTE24 FHOD3 CHD3 BCOR MLXIPL PIK3R2 NKX2-5 DNMT3A | 5.72e-04 | 403 | 45 | 11 | HP:0031653 |
| HumanPheno | Abnormal atrial septum morphology | CACNA1C MYH7 ZMPSTE24 RBM10 CHD3 BCOR LETM1 MLXIPL PIK3R2 JAG1 KMT2A NKX2-5 DNMT3A | 5.89e-04 | 544 | 45 | 13 | HP:0011994 |
| HumanPheno | Fatigable weakness | 6.06e-04 | 121 | 45 | 6 | HP:0003473 | |
| HumanPheno | Abnormal synaptic transmission at the neuromuscular junction | 6.33e-04 | 122 | 45 | 6 | HP:0003398 | |
| HumanPheno | Abnormal peripheral nervous system synaptic transmission | 6.33e-04 | 122 | 45 | 6 | HP:0030191 | |
| HumanPheno | Abnormal synaptic transmission | 6.33e-04 | 122 | 45 | 6 | HP:0012535 | |
| HumanPheno | Livedo | 6.61e-04 | 20 | 45 | 3 | HP:0033832 | |
| HumanPheno | Abnormal vascular physiology | TET2 CACNA1C FLNC MYH7 ZMPSTE24 CDH23 TCIRG1 NR3C1 USP8 NKX2-5 | 7.17e-04 | 348 | 45 | 10 | HP:0030163 |
| HumanPheno | Abnormal systemic arterial morphology | TET2 CACNA1C MYH7 ZMPSTE24 CDH23 TCIRG1 NR3C1 BCOR USP8 MLXIPL PIK3R2 JAG1 NKX2-5 CDON DNMT3A | 7.19e-04 | 708 | 45 | 15 | HP:0011004 |
| HumanPheno | Reduced number of intrahepatic bile ducts | 7.50e-04 | 5 | 45 | 2 | HP:0006571 | |
| HumanPheno | Abnormality of the adrenal glands | 7.73e-04 | 230 | 45 | 8 | HP:0000834 | |
| HumanPheno | Pulmonary artery stenosis | 7.87e-04 | 84 | 45 | 5 | HP:0004415 | |
| HumanPheno | Premature birth | 8.06e-04 | 177 | 45 | 7 | HP:0001622 | |
| HumanPheno | Abnormal thorax morphology | TET2 FLNC AARS1 MYH7 ABCA3 ZMPSTE24 RBM10 TCIRG1 CHD3 BCOR LETM1 LMOD3 MLXIPL TRMT10A CCDC47 PIK3R2 JAG1 RLIM KMT2A NKX2-5 CDON DNMT3A | 8.12e-04 | 1328 | 45 | 22 | HP:0000765 |
| HumanPheno | Mortality/Aging | CACNA1C FLNC MYH7 ABCA3 ZMPSTE24 RBM10 PEX14 FHOD3 ZNFX1 LMOD3 MLXIPL FXR1 CDON | 8.20e-04 | 563 | 45 | 13 | HP:0040006 |
| HumanPheno | Age of death | CACNA1C FLNC MYH7 ABCA3 ZMPSTE24 RBM10 PEX14 FHOD3 ZNFX1 LMOD3 MLXIPL FXR1 CDON | 8.20e-04 | 563 | 45 | 13 | HP:0011420 |
| HumanPheno | Abnormal coronary artery morphology | 9.20e-04 | 181 | 45 | 7 | HP:0006704 | |
| HumanPheno | Fatigue | TET2 SEMA4D MYH7 ABCA3 CDH23 NR3C1 BCOR MDM4 OPTN NKX2-5 SLC39A7 DNMT3A | 9.78e-04 | 500 | 45 | 12 | HP:0012378 |
| HumanPheno | Abnormal pulmonary artery morphology | 9.98e-04 | 133 | 45 | 6 | HP:0030966 | |
| HumanPheno | Chronic infection | 1.01e-03 | 23 | 45 | 3 | HP:0031035 | |
| HumanPheno | Suicidal ideation | 1.01e-03 | 23 | 45 | 3 | HP:0031589 | |
| HumanPheno | Left atrial enlargement | 1.01e-03 | 23 | 45 | 3 | HP:0031295 | |
| HumanPheno | Macular purpura | 1.02e-03 | 89 | 45 | 5 | HP:0031365 | |
| HumanPheno | Reduced bone mineral density | TET2 SEMA4D AARS1 ZMPSTE24 CDH23 TCIRG1 NR3C1 MDM4 LETM1 USP8 MLXIPL TRMT10A DMP1 | 1.05e-03 | 578 | 45 | 13 | HP:0004349 |
| HumanPheno | Ketonuria | 1.14e-03 | 53 | 45 | 4 | HP:0002919 | |
| HumanPheno | Paranoia | 1.15e-03 | 24 | 45 | 3 | HP:0011999 | |
| HumanPheno | Kyphosis | AARS1 MYH7 ZMPSTE24 BCOR LETM1 LMOD3 USP8 MLXIPL TRMT10A PIK3R2 JAG1 DNMT3A | 1.17e-03 | 510 | 45 | 12 | HP:0002808 |
| HumanPheno | Pedal edema | 1.22e-03 | 54 | 45 | 4 | HP:0010741 | |
| HumanPheno | Abnormal heart valve morphology | FLNC MYH7 ABCA3 ZMPSTE24 TCIRG1 FHOD3 CHD3 BCOR LETM1 MLXIPL PIK3R2 NKX2-5 DNMT3A | 1.24e-03 | 588 | 45 | 13 | HP:0001654 |
| HumanPheno | Abnormal left atrium morphology | 1.29e-03 | 25 | 45 | 3 | HP:0025579 | |
| HumanPheno | Adrenal hyperplasia | 1.29e-03 | 25 | 45 | 3 | HP:0008221 | |
| HumanPheno | Panic attack | 1.31e-03 | 55 | 45 | 4 | HP:0025269 | |
| MousePheno | abnormal circulating noradrenaline level | 1.81e-05 | 19 | 120 | 4 | MP:0005663 | |
| MousePheno | decreased circulating noradrenaline level | 2.11e-05 | 7 | 120 | 3 | MP:0005664 | |
| MousePheno | decreased noradrenaline level | 5.68e-05 | 25 | 120 | 4 | MP:0012574 | |
| Domain | Actin_CS | 6.06e-06 | 16 | 146 | 4 | IPR004001 | |
| Domain | ACTINS_2 | 7.88e-06 | 17 | 146 | 4 | PS00432 | |
| Domain | Actin/actin-like_CS | 1.01e-05 | 18 | 146 | 4 | IPR020902 | |
| Domain | Ank | POTEF DGKZ BCOR ANKZF1 POTEE RNASEL CASKIN1 ANKRD24 POTEI POTEJ | 1.26e-05 | 228 | 146 | 10 | PF00023 |
| Domain | ACTINS_ACT_LIKE | 1.27e-05 | 19 | 146 | 4 | PS01132 | |
| Domain | - | POTEF DGKZ BCOR ANKZF1 POTEE RNASEL CASKIN1 ANKRD24 POTEI POTEJ | 2.59e-05 | 248 | 146 | 10 | 1.25.40.20 |
| Domain | ANK | POTEF DGKZ BCOR ANKZF1 POTEE RNASEL CASKIN1 ANKRD24 POTEI POTEJ | 2.87e-05 | 251 | 146 | 10 | SM00248 |
| Domain | ANK_REPEAT | POTEF DGKZ BCOR ANKZF1 POTEE RNASEL CASKIN1 ANKRD24 POTEI POTEJ | 3.07e-05 | 253 | 146 | 10 | PS50088 |
| Domain | Ankyrin_rpt-contain_dom | POTEF DGKZ BCOR ANKZF1 POTEE RNASEL CASKIN1 ANKRD24 POTEI POTEJ | 3.18e-05 | 254 | 146 | 10 | IPR020683 |
| Domain | ANK_REP_REGION | POTEF DGKZ BCOR ANKZF1 POTEE RNASEL CASKIN1 ANKRD24 POTEI POTEJ | 3.18e-05 | 254 | 146 | 10 | PS50297 |
| Domain | Ankyrin_rpt | POTEF DGKZ BCOR ANKZF1 POTEE RNASEL CASKIN1 ANKRD24 POTEI POTEJ | 4.13e-05 | 262 | 146 | 10 | IPR002110 |
| Domain | Ank_2 | 4.97e-05 | 215 | 146 | 9 | PF12796 | |
| Domain | FXR_C1 | 6.07e-05 | 2 | 146 | 2 | IPR032172 | |
| Domain | ARHGEF5_35 | 6.07e-05 | 2 | 146 | 2 | PF15441 | |
| Domain | ARHGEF5/35_N | 6.07e-05 | 2 | 146 | 2 | IPR029212 | |
| Domain | FXR_C1 | 6.07e-05 | 2 | 146 | 2 | PF16096 | |
| Domain | DUF4605 | 6.07e-05 | 2 | 146 | 2 | IPR027953 | |
| Domain | DUF4605 | 6.07e-05 | 2 | 146 | 2 | PF15378 | |
| Domain | Actin | 9.57e-05 | 31 | 146 | 4 | IPR004000 | |
| Domain | Actin | 9.57e-05 | 31 | 146 | 4 | PF00022 | |
| Domain | ACTIN | 9.57e-05 | 31 | 146 | 4 | SM00268 | |
| Domain | Agenet | 1.81e-04 | 3 | 146 | 2 | PF05641 | |
| Domain | AGENET_LIKE | 1.81e-04 | 3 | 146 | 2 | PS51641 | |
| Domain | FXMRP1_C_core | 1.81e-04 | 3 | 146 | 2 | IPR022034 | |
| Domain | Agenet-like_dom | 1.81e-04 | 3 | 146 | 2 | IPR008395 | |
| Domain | FXMRP1_C_core | 1.81e-04 | 3 | 146 | 2 | PF12235 | |
| Domain | GPR40-rel_orph | 3.60e-04 | 4 | 146 | 2 | IPR013312 | |
| Domain | NA-bd_OB-fold | 4.85e-04 | 83 | 146 | 5 | IPR012340 | |
| Domain | zf-RanBP | 6.46e-04 | 22 | 146 | 3 | PF00641 | |
| Domain | ZnF_RBZ | 7.39e-04 | 23 | 146 | 3 | SM00547 | |
| Domain | G_PATCH | 7.39e-04 | 23 | 146 | 3 | PS50174 | |
| Domain | ZF_RANBP2_2 | 7.39e-04 | 23 | 146 | 3 | PS50199 | |
| Domain | G_patch | 7.39e-04 | 23 | 146 | 3 | SM00443 | |
| Domain | G_patch_dom | 7.39e-04 | 23 | 146 | 3 | IPR000467 | |
| Domain | G-patch | 7.39e-04 | 23 | 146 | 3 | PF01585 | |
| Domain | ZF_RANBP2_1 | 8.40e-04 | 24 | 146 | 3 | PS01358 | |
| Domain | Haem_d1 | 8.92e-04 | 6 | 146 | 2 | IPR011048 | |
| Domain | Znf_RanBP2 | 9.49e-04 | 25 | 146 | 3 | IPR001876 | |
| Domain | Znf_FYVE_PHD | 1.05e-03 | 147 | 146 | 6 | IPR011011 | |
| Domain | S1 | 1.65e-03 | 8 | 146 | 2 | PF00575 | |
| Domain | USP_1 | 2.20e-03 | 70 | 146 | 4 | PS00972 | |
| Domain | UCH | 2.32e-03 | 71 | 146 | 4 | PF00443 | |
| Domain | USP_2 | 2.32e-03 | 71 | 146 | 4 | PS00973 | |
| Domain | USP_3 | 2.44e-03 | 72 | 146 | 4 | PS50235 | |
| Domain | USP_dom | 2.44e-03 | 72 | 146 | 4 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 2.44e-03 | 72 | 146 | 4 | IPR001394 | |
| Domain | - | 2.62e-03 | 10 | 146 | 2 | 4.10.1060.10 | |
| Domain | S1 | 2.62e-03 | 10 | 146 | 2 | PS50126 | |
| Domain | RING | 2.78e-03 | 305 | 146 | 8 | SM00184 | |
| Domain | - | 2.83e-03 | 449 | 146 | 10 | 3.30.40.10 | |
| Domain | Znf_RING/FYVE/PHD | 3.31e-03 | 459 | 146 | 10 | IPR013083 | |
| Domain | S1 | 3.80e-03 | 12 | 146 | 2 | SM00316 | |
| Domain | S1_dom | 3.80e-03 | 12 | 146 | 2 | IPR022967 | |
| Domain | S1_domain | 3.80e-03 | 12 | 146 | 2 | IPR003029 | |
| Domain | Znf_C2H2_matrin | 3.80e-03 | 12 | 146 | 2 | IPR000690 | |
| Domain | Znf_RING | 4.16e-03 | 326 | 146 | 8 | IPR001841 | |
| Domain | Nucleotide-bd_a/b_plait | 4.22e-03 | 258 | 146 | 7 | IPR012677 | |
| Domain | RRM_1 | 5.93e-03 | 208 | 146 | 6 | PF00076 | |
| Domain | WH2 | 6.78e-03 | 16 | 146 | 2 | PF02205 | |
| Domain | RRM | 7.25e-03 | 217 | 146 | 6 | SM00360 | |
| Pubmed | EFCAB5 CACNA1C FLNC MYH7 ELOA2 ZMPSTE24 YBX1 POTEF CHD3 ZNF318 LETM1 POTEE LMOD3 USP8 FXR1 GTF3C1 BAZ1A CCDC47 EIF4G1 RBM5 DDX23 KMT2A EIF3A KIF5C POTEI POTEJ BSN | 1.19e-10 | 1442 | 150 | 27 | 35575683 | |
| Pubmed | GATAD2A YBX1 FXR2 RBBP6 RBM10 CHD3 DHX8 MYL12A FXR1 PAXBP1 GTF3C1 BAZ1A EIF4G1 SLTM RBM5 KMT2A EIF3A EIF3B SLC39A7 RBM34 | 8.02e-10 | 847 | 150 | 20 | 35850772 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NES FLNC AARS1 GATAD2A YBX1 SLU7 RICTOR UBXN1 DIS3 MYEF2 SRRT FXR1 GTF3C1 BAZ1A CCDC47 EIF4G1 RNF20 SLTM DDX23 PKN2 EIF3A EIF3B GOLGA4 RBM34 CCDC93 | 8.32e-10 | 1353 | 150 | 25 | 29467282 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | GATAD2A YBX1 FXR2 RBM10 SLU7 CHD3 SRRT PAXBP1 BAZ1A SUPT6H EIF4G1 RBM5 DDX23 KMT2A EIF3A EIF3B RBM34 | 1.25e-09 | 605 | 150 | 17 | 28977666 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | AARS1 GATAD2A YBX1 FXR2 OGFR UBXN1 ANKZF1 DIS3 LETM1 DHX8 MYL12A SRRT USP8 FXR1 PAXBP1 CCDC47 SUPT6H EIF4G1 RNF20 GOLIM4 DDX23 PKN2 EIF3A EIF3B GOLGA4 | 2.07e-09 | 1415 | 150 | 25 | 28515276 |
| Pubmed | TET2 FLNC AARS1 YBX1 RBM10 DIS3 SRRT FXR1 PAXBP1 EIF4G1 RBM5 OTUD4 DDX23 EIF3A EIF3B RBM34 | 2.47e-09 | 551 | 150 | 16 | 34728620 | |
| Pubmed | AARS1 ARHGEF5 FBRSL1 RICTOR ZNFX1 CHD3 NR3C1 ANKZF1 DIS3 LETM1 SRRT GTF3C1 ANAPC2 RNF20 SLTM KMT2A MARK2 | 3.64e-09 | 650 | 150 | 17 | 38777146 | |
| Pubmed | NES FLNC AARS1 FXR2 ZNF318 DIS3 MYEF2 DHX8 FXR1 GTF3C1 UTP25 SUPT6H EIF4G1 SLTM DDX23 KMT2A RBM34 | 3.89e-09 | 653 | 150 | 17 | 22586326 | |
| Pubmed | RBBP6 DGKZ RICTOR ZNF318 BCOR ANKZF1 MYEF2 DHX8 MYL12A POTEE SRRT CRACD PAXBP1 UTP25 BAZ1A CCDC47 SUPT6H EIF4G1 RBM5 GOLIM4 OTUD4 KMT2A EIF3A EIF3B MARK2 | 6.38e-09 | 1497 | 150 | 25 | 31527615 | |
| Pubmed | ELOA2 GATAD2A FXR2 FBRSL1 SLU7 ZNFX1 NR3C1 BCOR MYEF2 USP8 CCDC47 OTUD4 POTEJ BSN RBM34 SOAT1 | 1.93e-08 | 638 | 150 | 16 | 31182584 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NES FLNC GATAD2A YBX1 RBM10 CHD3 ZNF318 MYEF2 DHX8 SRRT FXR1 GTF3C1 BAZ1A SUPT6H EIF4G1 SLTM DDX23 EIF3A EIF3B MARK2 | 1.95e-08 | 1024 | 150 | 20 | 24711643 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 NES AARS1 ARHGEF5 POTEF RICTOR MDM4 SRRT KSR1 USP8 MLXIPL OPTN FXR1 EIF4G1 KMT2A KIF5C MARK2 GOLGA4 | 3.84e-08 | 861 | 150 | 18 | 36931259 |
| Pubmed | KIF21B NES DLGAP1 FXR2 MCC DGKZ ZNFX1 ZNF318 BCOR LETM1 MYEF2 FXR1 CASKIN1 EIF4G1 OTUD4 KIF5C BSN UNC79 GOLGA4 | 3.89e-08 | 963 | 150 | 19 | 28671696 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RBBP6 RBM10 RICTOR CHD3 ZNF318 BCOR SRRT PAXBP1 GTF3C1 EIF4G1 RNF20 OTUD4 KMT2A PKN2 EIF3B MARK2 GOLGA4 | 4.65e-08 | 774 | 150 | 17 | 15302935 |
| Pubmed | Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. | GATAD2A YBX1 RBM10 SLU7 MYEF2 SRRT FXR1 ANAPC2 TMEM132A RBM5 DDX23 | 4.67e-08 | 283 | 150 | 11 | 18854154 |
| Pubmed | GATAD2A YBX1 RBBP6 POTEF PEX14 ZNF318 MYL12A CRACD PAXBP1 RNF20 DDX23 EIF3B POTEI POTEJ | 4.70e-08 | 506 | 150 | 14 | 30890647 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | AARS1 YBX1 DIS3 LETM1 DHX8 MYL12A SRRT FXR1 PAXBP1 GTF3C1 BAZ1A CCDC47 SUPT6H EIF4G1 RNF20 SLTM RBM5 EIF3A EIF3B BSN GOLGA4 RBM34 SOAT1 | 5.15e-08 | 1425 | 150 | 23 | 30948266 |
| Pubmed | NES DLGAP1 FLNC DGKZ ZNFX1 CHD3 LETM1 MYEF2 MYL12A SRRT CRACD MLXIPL FXR1 CASKIN1 EIF4G1 KNDC1 OTUD4 KMT2A EIF3A KIF5C MARK2 BSN SLC39A7 | 5.55e-08 | 1431 | 150 | 23 | 37142655 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP17L7 FLNC FXR2 UBXN1 DIS3 DHX8 USP8 OPTN FBXO44 SUPT6H EIF4G1 OTUD4 DDX23 PKN2 EIF3A EIF3B MARK2 SLC39A7 AKAP7 | 7.56e-08 | 1005 | 150 | 19 | 19615732 |
| Pubmed | Evolution and expression of chimeric POTE-actin genes in the human genome. | 7.86e-08 | 3 | 150 | 3 | 17101985 | |
| Pubmed | CRYBG2 GATAD2A YBX1 RBBP6 CHD3 FXR1 PAXBP1 GTF3C1 BAZ1A SUPT6H SLTM KMT2A UNC79 | 1.42e-07 | 469 | 150 | 13 | 27634302 | |
| Pubmed | KIF21B NES FXR2 RBM10 MYL12A POTEE SRRT FXR1 UTP25 BAZ1A EIF4G1 DDX23 EIF3A KIF5C POTEJ | 1.95e-07 | 660 | 150 | 15 | 32780723 | |
| Pubmed | TET2 ZMPSTE24 GATAD2A YBX1 RBBP6 RBM10 FBRSL1 SLU7 CHD3 ZNF318 BCOR MYL12A SRRT GTF3C1 RLIM EIF4G1 OTUD4 KMT2A NKX2-5 EIF3A EIF3B RBM34 | 2.33e-07 | 1429 | 150 | 22 | 35140242 | |
| Pubmed | ZMPSTE24 FRMPD1 SLU7 DGKZ RICTOR CHD3 ZNF318 BCOR DIS3 LETM1 FXR1 PAXBP1 BAZ1A TTLL4 RLIM SLTM OTUD4 SERINC3 PJA1 | 2.42e-07 | 1084 | 150 | 19 | 11544199 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | BDP1 RBBP6 FBRSL1 ZNF318 CNTLN NR3C1 BCOR MDM4 DIS3 POTEE SUPT6H POTEI POTEJ BSN | 2.92e-07 | 588 | 150 | 14 | 38580884 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NES FLNC YBX1 OGFR RBM10 DIS3 MYL12A SRRT GTF3C1 UTP25 SUPT6H RNF20 SLTM RBM5 DDX23 PINX1 EIF3A SOAT1 | 2.98e-07 | 989 | 150 | 18 | 36424410 |
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 4.37e-07 | 15 | 150 | 4 | 16824795 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH7 CLGN GATAD2A FBRSL1 UBXN1 KSR1 OPTN GTF3C1 UTP25 PIK3R2 ANAPC2 EIF4G1 KMT2A PKN2 EIF3B MARK2 AKAP7 | 4.55e-07 | 910 | 150 | 17 | 36736316 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | YBX1 FXR2 RBBP6 FBRSL1 ZNFX1 MYEF2 DHX8 SRRT FXR1 SUPT6H SLTM RBM5 OTUD4 DDX23 EIF3A RBM34 | 4.65e-07 | 807 | 150 | 16 | 22681889 |
| Pubmed | GATAD2A YBX1 FXR2 CHD3 ANKZF1 MYL12A SRRT FXR1 PAXBP1 BAZ1A CCDC47 EIF4G1 RBM5 OTUD4 DDX23 PINX1 KMT2A MARK2 POTEJ SLC39A7 RBM34 | 4.90e-07 | 1371 | 150 | 21 | 36244648 | |
| Pubmed | TET2 AARS1 YBX1 FXR2 ZNFX1 MYL12A POTEE SRRT FXR1 CCDC47 EIF4G1 KMT2A EIF3A EIF3B RBM34 | 5.00e-07 | 711 | 150 | 15 | 33022573 | |
| Pubmed | YBX1 FXR2 RBBP6 RBM10 MYEF2 DHX8 MYL12A SRRT FXR1 PAXBP1 GTF3C1 EIF4G1 SLTM DDX23 RBM34 | 5.18e-07 | 713 | 150 | 15 | 29802200 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | AARS1 YBX1 FXR2 RBM10 SLU7 CHD3 DIS3 MYEF2 DHX8 SRRT FXR1 EIF4G1 DDX23 EIF3A EIF3B | 5.27e-07 | 714 | 150 | 15 | 28302793 |
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | ZNF280A FLNC GATAD2A SLU7 ZNF318 NR3C1 BCOR DIS3 FXR1 EIF4G1 RNF20 SLTM | 5.70e-07 | 444 | 150 | 12 | 34795231 |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | GATAD2A SLU7 NR3C1 MYEF2 GTF3C1 BAZ1A EIF4G1 SLTM RBM5 MARK2 RBM34 | 6.79e-07 | 370 | 150 | 11 | 22922362 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | GATAD2A RBBP6 RBM10 CHD3 ZNF318 BCOR DHX8 SRRT MLXIPL PAXBP1 GTF3C1 BAZ1A SUPT6H ANAPC2 RNF20 SLTM RBM5 DDX23 KMT2A SOAT1 | 8.20e-07 | 1294 | 150 | 20 | 30804502 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | GATAD2A YBX1 RBBP6 RBM10 SLU7 CHD3 ZNF318 BCOR MYL12A SRRT PAXBP1 BAZ1A EIF4G1 SLTM PINX1 KMT2A NKX2-5 | 8.70e-07 | 954 | 150 | 17 | 36373674 |
| Pubmed | RBBP6 CHD3 ITGAL DIS3 LETM1 SRRT FXR1 SUPT6H SLTM DDX23 PINX1 PKN2 EIF3B BSN | 1.01e-06 | 653 | 150 | 14 | 33742100 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NES FLNC YBX1 RBBP6 RBM10 MYEF2 DHX8 MYL12A SRRT PAXBP1 GTF3C1 SUPT6H EIF4G1 SLTM RBM5 DDX23 EIF3B DNMT3A | 1.08e-06 | 1082 | 150 | 18 | 38697112 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | GATAD2A YBX1 FXR2 RBBP6 SLU7 CHD3 DHX8 SRRT FXR1 GTF3C1 BAZ1A EIF4G1 PINX1 MARK2 RBM34 | 1.13e-06 | 759 | 150 | 15 | 35915203 |
| Pubmed | 1.56e-06 | 6 | 150 | 3 | 30573685 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | YBX1 FXR2 RBBP6 RBM10 SLU7 ANKZF1 MYEF2 POTEE FXR1 PAXBP1 EIF4G1 OTUD4 MARK2 RBM34 | 1.57e-06 | 678 | 150 | 14 | 30209976 |
| Pubmed | 1.58e-06 | 251 | 150 | 9 | 31076518 | ||
| Pubmed | AARS1 GATAD2A RBBP6 CHD3 UBXN1 DIS3 SRRT GTF3C1 BAZ1A SUPT6H EIF4G1 RNF20 SLTM DDX23 KMT2A EIF3A EIF3B | 1.99e-06 | 1014 | 150 | 17 | 32416067 | |
| Pubmed | 2.92e-06 | 347 | 150 | 10 | 16033648 | ||
| Pubmed | 2.95e-06 | 142 | 150 | 7 | 30217970 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 2.95e-06 | 271 | 150 | 9 | 32433965 | |
| Pubmed | KIF21B TET2 FBRSL1 BCOR DIS3 MYEF2 SUPT6H CASKIN1 TTLL4 ANAPC2 BSN PADI2 | 3.50e-06 | 529 | 150 | 12 | 14621295 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | FXR2 RBM10 RICTOR ZNF318 MYEF2 SRRT FXR1 GTF3C1 UTP25 SUPT6H RNF20 | 3.62e-06 | 440 | 150 | 11 | 34244565 |
| Pubmed | CLGN YBX1 FXR2 PEX14 FAM241B DIS3 LETM1 CRACD OPTN GTF3C1 CCDC47 EIF4G1 DDX23 KMT2A EIF3A EIF3B SLC39A7 RBM34 SOAT1 CCDC93 | 4.14e-06 | 1440 | 150 | 20 | 30833792 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | KIF21B FLNC GATAD2A YBX1 MCC DGKZ CHD3 SUPT6H EIF4G1 RNF20 DDX23 EIF3A EIF3B KIF5C CCDC93 | 4.29e-06 | 847 | 150 | 15 | 35235311 |
| Pubmed | mTOR-dependent stimulation of the association of eIF4G and eIF3 by insulin. | 4.33e-06 | 8 | 150 | 3 | 16541103 | |
| Pubmed | 4.83e-06 | 153 | 150 | 7 | 10718198 | ||
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FLNC MYH7 GATAD2A FRMPD1 SLU7 NR3C1 MDM4 MYEF2 CRACD FXR1 RNASEL GTF3C1 BAZ1A EIF4G1 NKX2-5 | 4.94e-06 | 857 | 150 | 15 | 25609649 |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | ABCA3 CLGN ZMPSTE24 YBX1 FXR1 CCDC47 JAG1 EIF3A SLC39A7 SOAT1 | 5.79e-06 | 375 | 150 | 10 | 32788342 |
| Pubmed | 5.79e-06 | 59 | 150 | 5 | 32382008 | ||
| Pubmed | 5.90e-06 | 103 | 150 | 6 | 32744500 | ||
| Pubmed | Opposing ISWI- and CHD-class chromatin remodeling activities orchestrate heterochromatic DNA repair. | 6.48e-06 | 9 | 150 | 3 | 25533843 | |
| Pubmed | 6.48e-06 | 9 | 150 | 3 | 16364570 | ||
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 7.03e-06 | 162 | 150 | 7 | 31363146 | |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 8.90e-06 | 235 | 150 | 8 | 30258100 | |
| Pubmed | UBAP2L arginine methylation by PRMT1 modulates stress granule assembly. | 9.23e-06 | 10 | 150 | 3 | 31114027 | |
| Pubmed | High Dub3 expression in mouse ESCs couples the G1/S checkpoint to pluripotency. | 9.23e-06 | 10 | 150 | 3 | 24207026 | |
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.02e-05 | 316 | 150 | 9 | 31665637 | |
| Pubmed | 1.06e-05 | 114 | 150 | 6 | 31553912 | ||
| Pubmed | NES ARHGEF19 GATAD2A ARHGEF5 PEX14 POTEE SRRT CCDC47 PIK3R2 RBM5 PINX1 KMT2A ARHGAP28 AJUBA GOLGA4 | 1.09e-05 | 916 | 150 | 15 | 32203420 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH7 FXR2 MCC UBXN1 MYL12A SRRT USP8 CCDC47 EIF4G1 OTUD4 DDX23 PINX1 SERINC3 EIF3A KIF5C MARK2 UNC79 SLC39A7 | 1.15e-05 | 1284 | 150 | 18 | 17353931 |
| Pubmed | 1.17e-05 | 244 | 150 | 8 | 29884807 | ||
| Pubmed | EFCAB5 FLNC AARS1 YBX1 PEX14 LETM1 SRRT MLXIPL EIF4G1 GOLIM4 EIF3A EIF3B KIF5C ALPK2 | 1.18e-05 | 809 | 150 | 14 | 32129710 | |
| Pubmed | 1.18e-05 | 322 | 150 | 9 | 26514267 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | GATAD2A YBX1 RBBP6 RBM10 NR3C1 DIS3 MYEF2 FXR1 CCDC47 SLTM EIF3A EIF3B MARK2 | 1.19e-05 | 701 | 150 | 13 | 30196744 |
| Pubmed | AARS1 RBM10 RICTOR ANKZF1 DIS3 MYL12A FXR1 GTF3C1 CCDC47 OTUD4 PINX1 KMT2A | 1.26e-05 | 601 | 150 | 12 | 33658012 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | AARS1 RBBP6 RBM10 PEX14 CHD3 ZNF318 NR3C1 BCOR DIS3 CRACD USP8 BAZ1A KMT2A PKN2 EIF3A | 1.37e-05 | 934 | 150 | 15 | 33916271 |
| Pubmed | 1.39e-05 | 250 | 150 | 8 | 33536335 | ||
| Pubmed | A Compendium of RNA-Binding Proteins that Regulate MicroRNA Biogenesis. | 1.56e-05 | 254 | 150 | 8 | 28431233 | |
| Pubmed | 1.68e-05 | 12 | 150 | 3 | 24695638 | ||
| Pubmed | YBX1 FXR2 RBBP6 RBM10 MYEF2 SRRT CRACD PAXBP1 SLTM DDX23 EIF3A EIF3B RBM34 | 1.84e-05 | 731 | 150 | 13 | 29298432 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25637492 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 30478340 | ||
| Pubmed | Double somatic mosaic mutations in TET2 and DNMT3A--origin of peripheral T cell lymphoma in a case. | 1.85e-05 | 2 | 150 | 2 | 25687841 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 33159179 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 35931086 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 34654019 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 22206009 | ||
| Pubmed | Intestinal FFA3 mediates obesogenic effects in mice on a Western diet. | 1.85e-05 | 2 | 150 | 2 | 35858247 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29728415 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 27924037 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 22506074 | ||
| Pubmed | Histone H2B ubiquitin ligase RNF20 is required for MLL-rearranged leukemia. | 1.85e-05 | 2 | 150 | 2 | 23412334 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24748202 | ||
| Pubmed | A primate-specific POTE-actin fusion protein plays a role in apoptosis. | 1.85e-05 | 2 | 150 | 2 | 19669888 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 36362376 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 28586478 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 35339897 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 34039392 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20399779 | ||
| Pubmed | Variants in NKX2-5 and FLNC Cause Dilated Cardiomyopathy and Sudden Cardiac Death. | 1.85e-05 | 2 | 150 | 2 | 30354339 | |
| Pubmed | Nestin modulates glucocorticoid receptor function by cytoplasmic anchoring. | 1.85e-05 | 2 | 150 | 2 | 19562035 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 28655780 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 9582025 | ||
| Interaction | TERF2IP interactions | XAGE2 GATAD2A RBBP6 OGFR SLU7 CHD3 ZNF318 BCOR DHX8 PAXBP1 GTF3C1 SUPT6H RNF20 RBM5 DDX23 PINX1 KMT2A DNMT3A | 1.18e-07 | 552 | 147 | 18 | int:TERF2IP |
| Interaction | FMR1 interactions | KIF21B DLGAP1 YBX1 FXR2 RBBP6 MCC ZNFX1 CHD3 NR3C1 POTEE FXR1 CASKIN1 EIF4G1 OTUD4 KIF5C BSN GOLGA4 | 3.99e-07 | 536 | 147 | 17 | int:FMR1 |
| Interaction | BMI1 interactions | YBX1 FXR2 CHD3 ZNF385B BCOR MYEF2 POTEE SRRT FXR1 PAXBP1 GTF3C1 BAZ1A SUPT6H EIF4G1 SLTM DDX23 KMT2A SLC39A7 | 1.54e-06 | 659 | 147 | 18 | int:BMI1 |
| Interaction | CSNK2A1 interactions | BDP1 GATAD2A YBX1 FXR2 RBM10 FBRSL1 DGKZ RICTOR XK CHD3 BCOR SRRT OPTN FXR1 BAZ1A SUPT6H KMT2A NKX2-5 EIF3A EIF3B KIF5C RBM34 | 1.70e-06 | 956 | 147 | 22 | int:CSNK2A1 |
| Interaction | DOT1L interactions | GATAD2A YBX1 FXR2 RBBP6 RBM10 CHD3 DHX8 MYL12A FXR1 PAXBP1 GTF3C1 BAZ1A EIF4G1 SLTM RBM5 KMT2A EIF3A EIF3B SLC39A7 RBM34 | 1.73e-06 | 807 | 147 | 20 | int:DOT1L |
| Interaction | SLFN11 interactions | BDP1 RBBP6 POTEF RBM10 CHD3 NR3C1 DHX8 POTEE GTF3C1 EIF4G1 EIF3A EIF3B DNMT3A | 3.95e-06 | 376 | 147 | 13 | int:SLFN11 |
| Interaction | CMTR1 interactions | 4.67e-06 | 218 | 147 | 10 | int:CMTR1 | |
| Interaction | MEN1 interactions | GATAD2A FXR2 RBBP6 RBM10 CHD3 DIS3 MYEF2 DHX8 SRRT FXR1 PAXBP1 GTF3C1 BAZ1A EIF4G1 RNF20 SLTM RBM5 DDX23 KMT2A EIF3A SLC39A7 RBM34 | 5.57e-06 | 1029 | 147 | 22 | int:MEN1 |
| Interaction | OBSL1 interactions | NES FLNC GATAD2A YBX1 FXR2 RBM10 MYEF2 DHX8 POTEE SRRT ARHGEF35 GTF3C1 SUPT6H ANAPC2 SLTM OTUD4 DDX23 EIF3A ALPK2 RBM34 | 9.15e-06 | 902 | 147 | 20 | int:OBSL1 |
| Interaction | ACTC1 interactions | GATAD2A YBX1 RBBP6 POTEF PEX14 CHD3 ZNF318 MYL12A POTEE CRACD PAXBP1 RLIM RNF20 DDX23 EIF3B POTEI POTEJ | 1.28e-05 | 694 | 147 | 17 | int:ACTC1 |
| Interaction | MYH10 interactions | TET2 FXR2 MCC RICTOR CHD3 MYL12A FXR1 PIK3R2 RLIM DDX23 EIF3B GOLGA4 | 1.32e-05 | 359 | 147 | 12 | int:MYH10 |
| Interaction | DHX40 interactions | RBBP6 ZNF318 NR3C1 DHX8 PAXBP1 SUPT6H SLTM DDX23 PINX1 RBM34 | 1.49e-05 | 249 | 147 | 10 | int:DHX40 |
| Interaction | SLU7 interactions | 1.93e-05 | 156 | 147 | 8 | int:SLU7 | |
| Interaction | TLE3 interactions | TET2 MYH7 RBBP6 FBRSL1 ZNF318 NR3C1 BCOR SRRT PAXBP1 OTUD4 KMT2A NKX2-5 | 2.09e-05 | 376 | 147 | 12 | int:TLE3 |
| Interaction | ACTG2 interactions | 2.84e-05 | 49 | 147 | 5 | int:ACTG2 | |
| Interaction | SYT6 interactions | 2.85e-05 | 120 | 147 | 7 | int:SYT6 | |
| Interaction | YWHAZ interactions | TET2 BDP1 DLGAP1 ARHGEF5 POTEF WASF3 MCC RICTOR BCOR MDM4 CRACD KSR1 USP8 MLXIPL OPTN PIK3R2 OTUD4 KMT2A EIF3A KIF5C MARK2 AJUBA PADI2 SOAT1 | 2.94e-05 | 1319 | 147 | 24 | int:YWHAZ |
| Interaction | SIRT7 interactions | NES FLNC AARS1 FXR2 ZNF318 DIS3 MYEF2 DHX8 FXR1 GTF3C1 UTP25 SUPT6H EIF4G1 SLTM DDX23 KMT2A RBM34 | 3.11e-05 | 744 | 147 | 17 | int:SIRT7 |
| Interaction | SNRNP70 interactions | GATAD2A YBX1 FXR2 RBBP6 RBM10 CHD3 MYEF2 DHX8 MYL12A SRRT TRMT10A OPTN FXR1 PAXBP1 GTF3C1 EIF4G1 SLTM DDX23 PINX1 RBM34 | 3.20e-05 | 984 | 147 | 20 | int:SNRNP70 |
| Interaction | CHD3 interactions | GATAD2A YBX1 FXR2 RBM10 CHD3 BCOR SRRT PAXBP1 BAZ1A SUPT6H EIF4G1 RBM5 DDX23 KMT2A EIF3A EIF3B RBM34 | 3.87e-05 | 757 | 147 | 17 | int:CHD3 |
| Interaction | YWHAE interactions | KIF21B TET2 DLGAP1 ARHGEF19 YBX1 ARHGEF5 POTEF RBM10 WASF3 MCC RICTOR CNTLN UBXN1 MDM4 ANKZF1 CRACD KSR1 USP8 PIK3R2 KMT2A EIF3A MARK2 SOAT1 | 4.00e-05 | 1256 | 147 | 23 | int:YWHAE |
| Interaction | YWHAH interactions | KIF21B TET2 NES DLGAP1 FXR2 ARHGEF5 POTEF RICTOR NR3C1 MDM4 SRRT KSR1 USP8 MLXIPL OPTN FXR1 EIF4G1 KMT2A KIF5C MARK2 GOLGA4 | 5.10e-05 | 1102 | 147 | 21 | int:YWHAH |
| Interaction | CHD4 interactions | GATAD2A FXR2 RBBP6 RBM10 SLU7 CHD3 DHX8 SRRT MLXIPL PAXBP1 FBXO44 SUPT6H EIF4G1 RBM5 DDX23 KMT2A EIF3A EIF3B RBM34 | 5.37e-05 | 938 | 147 | 19 | int:CHD4 |
| Interaction | SIRT6 interactions | MYH7 FXR2 RBM10 PEX14 RICTOR CHD3 ZNF318 BCOR MYEF2 SRRT FXR1 GTF3C1 UTP25 SUPT6H RNF20 | 5.70e-05 | 628 | 147 | 15 | int:SIRT6 |
| Interaction | DHX8 interactions | 5.79e-05 | 292 | 147 | 10 | int:DHX8 | |
| Interaction | YWHAQ interactions | KIF21B TET2 DLGAP1 MYH7 ARHGEF5 POTEF RICTOR MDM4 KSR1 USP8 MLXIPL OPTN BAZ1A PIK3R2 EIF4G1 RNF20 KMT2A KIF5C MARK2 UNC79 SOAT1 | 6.26e-05 | 1118 | 147 | 21 | int:YWHAQ |
| Interaction | SNRNP40 interactions | GATAD2A RBBP6 RBM10 SLU7 CHD3 ZNF318 BCOR DHX8 SRRT PAXBP1 SUPT6H RBM5 DDX23 PINX1 KMT2A | 6.68e-05 | 637 | 147 | 15 | int:SNRNP40 |
| Interaction | SRPK2 interactions | YBX1 FXR2 RBBP6 MYEF2 DHX8 SRRT FXR1 PAXBP1 OTOF BAZ1A SUPT6H EIF4G1 SLTM DDX23 EIF3A RBM34 | 7.13e-05 | 717 | 147 | 16 | int:SRPK2 |
| Interaction | NR3C1 interactions | ELOA2 ZMPSTE24 GATAD2A FXR2 FBRSL1 SLU7 PEX14 ZNFX1 NR3C1 BCOR MYEF2 USP8 CCDC47 PDP1 OTUD4 POTEJ BSN RBM34 SOAT1 | 8.84e-05 | 974 | 147 | 19 | int:NR3C1 |
| Interaction | AATF interactions | FXR2 RBM10 CHD3 NR3C1 SRRT FXR1 UTP25 SLTM DDX23 PINX1 EIF3A | 1.01e-04 | 376 | 147 | 11 | int:AATF |
| Interaction | YWHAG interactions | KIF21B TET2 DLGAP1 AARS1 ARHGEF5 POTEF MCC RICTOR CNTLN MDM4 CRACD KSR1 USP8 MLXIPL OPTN FXR1 BAZ1A EIF4G1 KMT2A PKN2 KIF5C MARK2 | 1.05e-04 | 1248 | 147 | 22 | int:YWHAG |
| Interaction | FHIP2B interactions | 1.06e-04 | 34 | 147 | 4 | int:FHIP2B | |
| Interaction | SMG7 interactions | 1.20e-04 | 319 | 147 | 10 | int:SMG7 | |
| Interaction | EED interactions | AARS1 GATAD2A YBX1 FXR2 RBBP6 RICTOR CHD3 BCOR DIS3 MYEF2 SRRT FXR1 GTF3C1 BAZ1A SUPT6H EIF4G1 SLTM RBM5 EIF3A EIF3B PJA1 MARK2 SOAT1 DNMT3A | 1.23e-04 | 1445 | 147 | 24 | int:EED |
| Interaction | CIT interactions | NES DLGAP1 FLNC AARS1 CLGN YBX1 FXR2 RBBP6 STXBP5 RBM10 CHD3 DHX8 FXR1 PAXBP1 SUPT6H EIF4G1 RBM5 DDX23 KMT2A EIF3A EIF3B POTEJ SLC39A7 GOLGA4 | 1.30e-04 | 1450 | 147 | 24 | int:CIT |
| Interaction | CYFIP2 interactions | 1.33e-04 | 323 | 147 | 10 | int:CYFIP2 | |
| Interaction | NUPR1 interactions | KIF21B NES FXR2 RBM10 MYL12A POTEE SRRT FXR1 UTP25 BAZ1A EIF4G1 DDX23 EIF3A KIF5C POTEJ | 1.44e-04 | 683 | 147 | 15 | int:NUPR1 |
| Interaction | YWHAB interactions | KIF21B TET2 DLGAP1 ARHGEF5 POTEF WASF3 MCC RICTOR CNTLN MDM4 KSR1 USP8 OPTN PIK3R2 EIF4G1 KMT2A KIF5C MARK2 SOAT1 | 1.49e-04 | 1014 | 147 | 19 | int:YWHAB |
| Interaction | DDX27 interactions | 1.55e-04 | 329 | 147 | 10 | int:DDX27 | |
| Interaction | MECP2 interactions | NES FLNC ARHGEF19 YBX1 FXR2 RBBP6 ARHGEF5 RBM10 MYEF2 DHX8 MYL12A SRRT PAXBP1 GTF3C1 BAZ1A SUPT6H EIF4G1 SLTM RBM5 DDX23 EIF3B DNMT3A | 1.63e-04 | 1287 | 147 | 22 | int:MECP2 |
| Interaction | HDLBP interactions | GATAD2A YBX1 FXR2 RICTOR CHD3 ANKZF1 SRRT FXR1 PAXBP1 CCDC47 EIF4G1 RBM5 DDX23 KMT2A MARK2 POTEJ RBM34 | 1.70e-04 | 855 | 147 | 17 | int:HDLBP |
| Interaction | MIRLET7I interactions | 1.90e-04 | 114 | 147 | 6 | int:MIRLET7I | |
| Interaction | WEE2-AS1 interactions | 1.96e-04 | 163 | 147 | 7 | int:WEE2-AS1 | |
| Interaction | NUP43 interactions | GATAD2A RBBP6 RICTOR CHD3 ZNF318 BCOR DHX8 SRRT PAXBP1 BAZ1A SUPT6H RLIM EIF4G1 KMT2A | 1.98e-04 | 625 | 147 | 14 | int:NUP43 |
| Interaction | EP300 interactions | YBX1 RBBP6 RICTOR CHD3 NR3C1 MDM4 ITGAL DIS3 LETM1 SRRT MLXIPL FXR1 GTF3C1 SUPT6H ANAPC2 POLI SLTM DDX23 PINX1 PKN2 EIF3B BSN AJUBA | 2.06e-04 | 1401 | 147 | 23 | int:EP300 |
| Interaction | DDX23 interactions | RBBP6 RBM10 SLU7 CHD3 DHX8 PAXBP1 SUPT6H SLTM RBM5 DDX23 PINX1 RBM34 | 2.13e-04 | 480 | 147 | 12 | int:DDX23 |
| Interaction | MIRLET7G interactions | 2.19e-04 | 117 | 147 | 6 | int:MIRLET7G | |
| Interaction | CSNK2A2 interactions | ZMPSTE24 GATAD2A FXR2 RBM10 FBRSL1 DGKZ NR3C1 BCOR OPTN GTF3C1 RBM5 KMT2A EIF3A EIF3B KIF5C | 2.48e-04 | 718 | 147 | 15 | int:CSNK2A2 |
| Interaction | SUZ12 interactions | AARS1 GATAD2A YBX1 FXR2 CHD3 FXR1 PAXBP1 GTF3C1 SLTM RBM5 DDX23 PJA1 SLC39A7 RBM34 | 2.69e-04 | 644 | 147 | 14 | int:SUZ12 |
| Interaction | SGCD interactions | 2.86e-04 | 18 | 147 | 3 | int:SGCD | |
| Interaction | H2BC8 interactions | GATAD2A SLU7 CHD3 BCOR DHX8 POTEE GTF3C1 BAZ1A CCDC47 PINX1 KMT2A RBM34 DNMT3A | 3.13e-04 | 576 | 147 | 13 | int:H2BC8 |
| Interaction | PHC1P1 interactions | 3.14e-04 | 4 | 147 | 2 | int:PHC1P1 | |
| Interaction | MBD3 interactions | 3.23e-04 | 295 | 147 | 9 | int:MBD3 | |
| Interaction | SRSF6 interactions | YBX1 RBBP6 RBM10 CHD3 DHX8 SRRT FXR1 PAXBP1 RBM5 DDX23 KMT2A RBM34 | 3.26e-04 | 503 | 147 | 12 | int:SRSF6 |
| Interaction | FOXP3 interactions | GATAD2A SLU7 NR3C1 MYEF2 GTF3C1 BAZ1A EIF4G1 SLTM RBM5 MARK2 RBM34 | 3.36e-04 | 432 | 147 | 11 | int:FOXP3 |
| Interaction | TRIOBP interactions | 3.41e-04 | 127 | 147 | 6 | int:TRIOBP | |
| Interaction | H2AC4 interactions | FLNC YBX1 FXR2 CHD3 GTF3C1 BAZ1A SUPT6H RLIM RNF20 DDX23 KMT2A UNC79 | 3.44e-04 | 506 | 147 | 12 | int:H2AC4 |
| Interaction | SMC5 interactions | GATAD2A YBX1 RBBP6 RBM10 SLU7 CHD3 ZNF318 BCOR MYL12A SRRT PAXBP1 BAZ1A EIF4G1 SLTM PINX1 KMT2A NKX2-5 PJA1 | 3.66e-04 | 1000 | 147 | 18 | int:SMC5 |
| Cytoband | 2q21.1 | 4.05e-05 | 58 | 150 | 4 | 2q21.1 | |
| Cytoband | 18p11.31 | 1.17e-04 | 29 | 150 | 3 | 18p11.31 | |
| GeneFamily | Ankyrin repeat domain containing|POTE ankyrin domain containing | 6.56e-07 | 13 | 102 | 4 | 685 | |
| GeneFamily | Ankyrin repeat domain containing | 9.23e-06 | 242 | 102 | 9 | 403 | |
| GeneFamily | G-patch domain containing|Minor histocompatibility antigens | 2.48e-04 | 22 | 102 | 3 | 579 | |
| GeneFamily | RNA binding motif containing | 1.31e-03 | 213 | 102 | 6 | 725 | |
| GeneFamily | Eukaryotic translation initiation factor 3 | 2.36e-03 | 13 | 102 | 2 | 1121 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | KIF21B BDP1 CACNA1C ABCA3 STXBP5 ZBTB43 RICTOR FHOD3 XK CHD3 ZNF318 CHGA LMOD3 OPTN KIAA1549L PDP1 CASKIN1 OTUD4 KIF5C BSN UNC79 CDON | 3.16e-07 | 1106 | 149 | 22 | M39071 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BDP1 PENK TCIRG1 SLU7 MYEF2 USP8 OPTN FXR1 BAZ1A CCDC47 JAG1 RNF20 GOLIM4 EIF3A GOLGA4 | 5.35e-06 | 656 | 149 | 15 | M18979 |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 8.18e-06 | 177 | 149 | 8 | M9401 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN | 1.91e-05 | 199 | 149 | 8 | M7319 | |
| Coexpression | GSE14415_INDUCED_VS_NATURAL_TREG_UP | 2.38e-05 | 149 | 149 | 7 | M2968 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | KIF21B CACNA1C FXR2 PENK CRACD OPTN KIAA1549L PIK3R2 TMEM132A KNDC1 PJA1 AKAP7 | 2.40e-05 | 488 | 149 | 12 | M39104 |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | GATAD2A FXR2 RBBP6 RBM10 FBRSL1 SRRT FBXO44 EIF3B MARK2 CCDC93 | 2.50e-05 | 338 | 149 | 10 | M17094 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA2 | KIF21B ABCA3 STXBP5 MCC FHOD3 ZNFX1 OPTN PDP1 CASKIN1 ARHGAP28 BSN CDON | 3.90e-05 | 513 | 149 | 12 | M39069 |
| Coexpression | BROWNE_HCMV_INFECTION_20HR_UP | 6.23e-05 | 235 | 149 | 8 | M6122 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_UP | 7.50e-05 | 123 | 149 | 6 | M2080 | |
| Coexpression | KARLSSON_TGFB1_TARGETS_UP | 8.96e-05 | 127 | 149 | 6 | MM1289 | |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | ZMPSTE24 GATAD2A MCC LETM1 RLIM EIF4G1 SLTM OTUD4 EIF3B CCDC93 | 1.20e-04 | 408 | 149 | 10 | M11891 |
| Coexpression | MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP | ZMPSTE24 GATAD2A MCC LETM1 RLIM EIF4G1 SLTM OTUD4 EIF3B CCDC93 | 1.38e-04 | 415 | 149 | 10 | MM1028 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | 1.43e-04 | 417 | 149 | 10 | M39224 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.48e-04 | 199 | 149 | 7 | M7254 | |
| Coexpression | GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP | 1.48e-04 | 199 | 149 | 7 | M7325 | |
| Coexpression | GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN | 1.48e-04 | 199 | 149 | 7 | M7332 | |
| Coexpression | GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN | 1.48e-04 | 199 | 149 | 7 | M6932 | |
| Coexpression | GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP | 1.52e-04 | 200 | 149 | 7 | M9764 | |
| Coexpression | GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP | 1.52e-04 | 200 | 149 | 7 | M3666 | |
| Coexpression | GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN | 1.52e-04 | 200 | 149 | 7 | M3659 | |
| Coexpression | PEREZ_TP53_TARGETS | SEMA4D FLNC CRYBG2 MMP28 ZBTB43 FBRSL1 MCC DGKZ ZNFX1 BCOR CRACD KSR1 PAXBP1 FBXO44 KNDC1 GPCPD1 DISP2 AKAP7 | 1.67e-04 | 1201 | 149 | 18 | M4391 |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-intermediate_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.75e-07 | 190 | 150 | 8 | 5f1863bce9400b7c932f0e4d0e012ec4e8d7e555 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.06e-07 | 200 | 150 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.49e-06 | 165 | 150 | 7 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.29e-06 | 176 | 150 | 7 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 2.85e-06 | 182 | 150 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 2.96e-06 | 183 | 150 | 7 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | cellseq2-Epithelial-Epithelial_Alveolar-AT2-AT2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.35e-06 | 194 | 150 | 7 | df835578d86a49ae5af5632152fbab9548c0a448 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Alveolar|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.35e-06 | 194 | 150 | 7 | 0715f2d55f4a6d2edda1b3dc52f12d25ce59eb10 | |
| ToppCell | cellseq2-Epithelial-Epithelial_Alveolar-AT2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.35e-06 | 194 | 150 | 7 | a4f7cd507eba40985d82635bbae28c7f5703f883 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 5.31e-06 | 200 | 150 | 7 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.67e-05 | 159 | 150 | 6 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-05 | 170 | 150 | 6 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 170 | 150 | 6 | d99f61aa85ea3f775165cb433421e6f1cda4f96b | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 170 | 150 | 6 | 615cf9639c66b3fbd984ebe3f345280005d3c38a | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.59e-05 | 172 | 150 | 6 | d65ffff3e341af34a043a0d802d7ba4b69de36e9 | |
| ToppCell | Epithelial-Epithelial-C_(AT2)|Epithelial / shred on cell class and cell subclass (v4) | 2.68e-05 | 173 | 150 | 6 | f57cbf5bd2a9e5db47b4919e9cd5e50781c1a990 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Lymphocytic-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-05 | 174 | 150 | 6 | 6987fe7959afce347282f632abc16d800ccab7c4 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.45e-05 | 181 | 150 | 6 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.56e-05 | 182 | 150 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.79e-05 | 184 | 150 | 6 | fe9ea4d0e0be820e95eaf9bb42a5560d0e177574 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-05 | 184 | 150 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.90e-05 | 185 | 150 | 6 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 4.02e-05 | 186 | 150 | 6 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | PND03-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.02e-05 | 186 | 150 | 6 | 7950e03ea080238c168b9d807e217f459acdfb28 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.14e-05 | 187 | 150 | 6 | 6ab51e17a7782c2ae6394cad813dc3a2cde70c89 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.14e-05 | 187 | 150 | 6 | e176b5b051690f840f3b12c8f7c4cc10cbe2bbae | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | 3d838da870623a6a278ddc8e6cedca85d9877e50 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.40e-05 | 189 | 150 | 6 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.40e-05 | 189 | 150 | 6 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.53e-05 | 190 | 150 | 6 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.53e-05 | 190 | 150 | 6 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | c172c9e17b893b290e4aa8af5e5e4cd3e4818372 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 715f5b449b8e075959c05a5b38389df319663164 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 192 | 150 | 6 | f6a4e348406a852ace9fb21db8fbdff539217645 | |
| ToppCell | droplet-Pancreas-Endocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 192 | 150 | 6 | 0dfd1e9896c34aee0f842f8de5d0e3af62a15f68 | |
| ToppCell | droplet-Heart-nan-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.80e-05 | 192 | 150 | 6 | 1a0c25106ae08eac912a4edd5fc1a3ee776f69c2 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.94e-05 | 193 | 150 | 6 | db9378c5bb5c27b321957a05dcabf40e97a3b725 | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 194 | 150 | 6 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.08e-05 | 194 | 150 | 6 | 2dcc3b99dbedaf8a6916891c85091ddb79d7ee31 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 194 | 150 | 6 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.23e-05 | 195 | 150 | 6 | a1478021a3ed0e779716393124ca2a7770c433b7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.23e-05 | 195 | 150 | 6 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.38e-05 | 196 | 150 | 6 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.38e-05 | 196 | 150 | 6 | 4bdc304c0c9d8bebe1a6a8a27e44acd1e8113725 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.39e-05 | 120 | 150 | 5 | a6d0406a174d46ce06b41280292931954af88a59 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 5.53e-05 | 197 | 150 | 6 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-05 | 198 | 150 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-05 | 198 | 150 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-05 | 198 | 150 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 5.69e-05 | 198 | 150 | 6 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.69e-05 | 198 | 150 | 6 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.85e-05 | 199 | 150 | 6 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-05 | 200 | 150 | 6 | ea1e3eeddbc398ac97863120f7aa3f17569ca12a | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-OPC_related-Oligodendrocyte/OPC|6m / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-05 | 200 | 150 | 6 | 4a57f2f2dc6e2402ac4772b5cd38e033a6f1adee | |
| ToppCell | TCGA-Brain-Primary_Tumor-Glioblastoma-Primary_GBM-11|TCGA-Brain / Sample_Type by Project: Shred V9 | 6.07e-05 | 63 | 150 | 4 | d7dc1356a60cb527fe668328d5375f352239d911 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.01e-04 | 137 | 150 | 5 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.08e-04 | 139 | 150 | 5 | 9e2a84d5ed7232b70eadbba754d9ca13f2d50fe9 | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.16e-04 | 141 | 150 | 5 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | LA-15._Ventricular_Cardiomyocyte_III|LA / Chamber and Cluster_Paper | 1.41e-04 | 147 | 150 | 5 | 8970eb6b82589f39439c61a57d999661ec8342de | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 6.11e-05 | 50 | 91 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | GSK-3beta Inhibitor VIII; Up 200; 10uM; MCF7; HT_HG-U133A | SEMA4D ZBTB43 PEX14 UBXN1 NR3C1 DIS3 SRRT RNASEL SUPT6H MARK2 | 6.46e-07 | 196 | 148 | 10 | 7092_UP |
| Drug | Cloxacillin sodium salt [642-78-4]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 7.78e-07 | 200 | 148 | 10 | 7483_UP | |
| Drug | Hesperidin [520-26-3]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 5.42e-06 | 195 | 148 | 9 | 5313_DN | |
| Drug | Reserpinic acid hydrochloride; Down 200; 9.2uM; PC3; HT_HG-U133A | 6.14e-06 | 198 | 148 | 9 | 6603_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.13e-05 | 177 | 148 | 8 | 4821_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.50e-05 | 181 | 148 | 8 | 5987_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.92e-05 | 185 | 148 | 8 | 1637_UP | |
| Drug | Y-27632; Up 200; 3uM; MCF7; HT_HG-U133A_EA | 3.95e-05 | 193 | 148 | 8 | 948_UP | |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; MCF7; HT_HG-U133A | 4.10e-05 | 194 | 148 | 8 | 3526_UP | |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 4.25e-05 | 195 | 148 | 8 | 7037_UP | |
| Drug | Trimeprazine tartrate [4330-99-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 4.25e-05 | 195 | 148 | 8 | 3478_UP | |
| Drug | Sotalol hydrochloride [959-24-0]; Up 200; 13uM; MCF7; HT_HG-U133A | 4.40e-05 | 196 | 148 | 8 | 7338_UP | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; PC3; HT_HG-U133A | 4.40e-05 | 196 | 148 | 8 | 4331_UP | |
| Drug | Hexestrol [84-16-2]; Up 200; 14.8uM; PC3; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 5776_UP | |
| Drug | N6,2-O-dibutyryladenosine 3,5-cyclic monophosphate sodium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 4.57e-05 | 197 | 148 | 8 | 959_UP | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 2868_DN | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; MCF7; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 4958_DN | |
| Drug | Acyclovir [59277-89-3]; Up 200; 17.8uM; MCF7; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 5278_UP | |
| Drug | Neomycin sulfate [1405-10-3]; Up 200; 4.2uM; PC3; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 5867_UP | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 7003_DN | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; PC3; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 6622_DN | |
| Drug | Nafronyl oxalate [3200-06-4]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 2622_UP | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 4.90e-05 | 199 | 148 | 8 | 3410_DN | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; PC3; HT_HG-U133A | 4.90e-05 | 199 | 148 | 8 | 5838_DN | |
| Drug | prednisolone; Up 200; 1uM; MCF7; HG-U133A | 4.90e-05 | 199 | 148 | 8 | 265_UP | |
| Drug | Acetazolamide [59-66-5]; Down 200; 18uM; MCF7; HT_HG-U133A | 4.90e-05 | 199 | 148 | 8 | 7461_DN | |
| Drug | ZP-S | 7.34e-05 | 13 | 148 | 3 | CID000162569 | |
| Drug | tert-butylamine | 9.58e-05 | 37 | 148 | 4 | CID000006385 | |
| Drug | Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.05e-04 | 165 | 148 | 7 | 3851_UP | |
| Drug | nitrogen peroxide | 1.16e-04 | 15 | 148 | 3 | CID003032552 | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.41e-04 | 173 | 148 | 7 | 1050_UP | |
| Drug | Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A | 1.46e-04 | 174 | 148 | 7 | 6048_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.51e-04 | 175 | 148 | 7 | 3428_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.62e-04 | 177 | 148 | 7 | 3395_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 1.68e-04 | 178 | 148 | 7 | 6454_UP | |
| Drug | Trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 1.74e-04 | 179 | 148 | 7 | 6993_UP | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A | 1.80e-04 | 180 | 148 | 7 | 5203_UP | |
| Drug | Ellipticine [519-23-3]; Down 200; 16.2uM; HL60; HG-U133A | 1.80e-04 | 180 | 148 | 7 | 1765_DN | |
| Drug | cupric oxide | YBX1 RBBP6 ZBTB43 SLU7 FAM241B MLXIPL RLIM POLI OTUD4 EIF3B AJUBA ALPK2 | 2.32e-04 | 543 | 148 | 12 | ctd:C030973 |
| Drug | AC1MQ5W2 | 2.42e-04 | 19 | 148 | 3 | CID003396480 | |
| Drug | cycloheptene | 2.50e-04 | 4 | 148 | 2 | CID000012363 | |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; MCF7; HT_HG-U133A | 2.51e-04 | 190 | 148 | 7 | 5237_UP | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.59e-04 | 191 | 148 | 7 | 4168_DN | |
| Drug | Astemizole [68844-77-9]; Down 200; 8.8uM; HL60; HG-U133A | 2.67e-04 | 192 | 148 | 7 | 1365_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 2.76e-04 | 193 | 148 | 7 | 5256_DN | |
| Drug | Mebeverine hydrochloride [2753-45-9]; Up 200; 8.6uM; PC3; HT_HG-U133A | 2.76e-04 | 193 | 148 | 7 | 7147_UP | |
| Drug | AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A | 2.76e-04 | 193 | 148 | 7 | 6920_UP | |
| Drug | Ethynodiol diacetate [297-76-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.76e-04 | 193 | 148 | 7 | 5024_DN | |
| Drug | Leflunomide [75706-12-6]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 2.76e-04 | 193 | 148 | 7 | 7238_UP | |
| Drug | Benfluorex hydrochloride [23642-66-2]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 2.84e-04 | 194 | 148 | 7 | 2621_UP | |
| Drug | diclofenac sodium; Down 200; 10uM; MCF7; HG-U133A | 2.93e-04 | 195 | 148 | 7 | 333_DN | |
| Drug | Naproxen [22204-53-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A | 2.93e-04 | 195 | 148 | 7 | 1706_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 2.93e-04 | 195 | 148 | 7 | 7539_DN | |
| Drug | Dimethadione [695-53-4]; Down 200; 31uM; PC3; HT_HG-U133A | 2.93e-04 | 195 | 148 | 7 | 4607_DN | |
| Drug | Molindone hydrochloride [15622-65-8]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.93e-04 | 195 | 148 | 7 | 4199_DN | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 2.93e-04 | 195 | 148 | 7 | 4318_UP | |
| Drug | ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A | 2.93e-04 | 195 | 148 | 7 | 6918_UP | |
| Drug | Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.03e-04 | 196 | 148 | 7 | 2056_DN | |
| Drug | Methoxamine hydrochloride [61-16-5]; Down 200; 16.2uM; PC3; HT_HG-U133A | 3.03e-04 | 196 | 148 | 7 | 6627_DN | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A_EA | 3.03e-04 | 196 | 148 | 7 | 990_UP | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; HL60; HT_HG-U133A | 3.03e-04 | 196 | 148 | 7 | 2571_DN | |
| Drug | ICI182,780; Up 200; 1uM; MCF7; HT_HG-U133A | 3.03e-04 | 196 | 148 | 7 | 7091_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 200uM; MCF7; HT_HG-U133A | 3.03e-04 | 196 | 148 | 7 | 5574_DN | |
| Drug | Gemfibrozil [25812-30-0]; Up 200; 16uM; MCF7; HT_HG-U133A | 3.03e-04 | 196 | 148 | 7 | 5488_UP | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.03e-04 | 196 | 148 | 7 | 5446_DN | |
| Drug | Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A | 3.03e-04 | 196 | 148 | 7 | 2827_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A | 3.03e-04 | 196 | 148 | 7 | 5577_DN | |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 6952_UP | |
| Drug | Deoxycorticosterone [64-85-7]; Down 200; 12.2uM; HL60; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 3099_DN | |
| Drug | rofecoxib; Down 200; 10uM; HL60; HG-U133A | 3.12e-04 | 197 | 148 | 7 | 371_DN | |
| Drug | Sulfamonomethoxine [1220-83-3]; Up 200; 14.2uM; PC3; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 5843_UP | |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 2783_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Up 200; 0.1uM; PC3; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 1219_UP | |
| Drug | Hexestrol [84-16-2]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 6077_DN | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 5576_DN | |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 5301_DN | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; MCF7; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 3372_DN | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 2620_UP | |
| Drug | Betonicine [515-25-3]; Down 200; 25.2uM; MCF7; HT_HG-U133A | 3.12e-04 | 197 | 148 | 7 | 6063_DN | |
| Drug | Minoxidil [38304-91-5]; Up 200; 19.2uM; PC3; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 4216_UP | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 4750_DN | |
| Drug | Tremorine dihydrochloride [300-68-5]; Down 200; 15uM; PC3; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 5799_DN | |
| Drug | Nafcillin sodium salt monohydrate [7177-50-6]; Down 200; 8.8uM; HL60; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 2983_DN | |
| Drug | Demecarium bromide [56-94-0]; Down 200; 5.6uM; MCF7; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 6269_DN | |
| Drug | Thioperamide maleate [106243-16-7]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 5635_UP | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Down 200; 13.2uM; MCF7; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 6827_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Down 200; 8.2uM; PC3; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 6287_DN | |
| Drug | Sulfisoxazole [127-69-5]; Down 200; 15uM; MCF7; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 5622_DN | |
| Drug | Amrinone [60719-84-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 2724_DN | |
| Drug | Urapidil hydrochloride [64887-14-5]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 5295_UP | |
| Drug | Dimenhydrinate [523-87-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 7431_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 5242_DN | |
| Drug | 6-thioguanine; Down 200; 10uM; MCF7; HG-U133A | 3.22e-04 | 198 | 148 | 7 | 642_DN | |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.22e-04 | 198 | 148 | 7 | 5387_UP | |
| Drug | Cinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 3.32e-04 | 199 | 148 | 7 | 3463_DN | |
| Drug | Ornidazole [16773-42-5]; Up 200; 18.2uM; PC3; HT_HG-U133A | 3.32e-04 | 199 | 148 | 7 | 2109_UP | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Up 200; 9.4uM; PC3; HG-U133A | 3.32e-04 | 199 | 148 | 7 | 1920_UP | |
| Drug | clozapine; Up 200; 10uM; PC3; HT_HG-U133A | 3.32e-04 | 199 | 148 | 7 | 1229_UP | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 3.32e-04 | 199 | 148 | 7 | 997_DN | |
| Drug | Nifedipine [21829-25-4]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.32e-04 | 199 | 148 | 7 | 6006_DN | |
| Disease | Prostatic Neoplasms | TET2 ARHGEF5 WASF3 PENK CHD3 NR3C1 RNASEL FBXO44 PIK3R2 PDP1 RLIM KMT2A SERINC3 EIF3A GOLGA4 | 3.44e-07 | 616 | 143 | 15 | C0033578 |
| Disease | Malignant neoplasm of prostate | TET2 ARHGEF5 WASF3 PENK CHD3 NR3C1 RNASEL FBXO44 PIK3R2 PDP1 RLIM KMT2A SERINC3 EIF3A GOLGA4 | 3.44e-07 | 616 | 143 | 15 | C0376358 |
| Disease | congenital heart disease (implicated_via_orthology) | 1.09e-06 | 69 | 143 | 6 | DOID:1682 (implicated_via_orthology) | |
| Disease | Retinoblastoma | 6.97e-05 | 3 | 143 | 2 | C0035335 | |
| Disease | fragile X syndrome (implicated_via_orthology) | 6.97e-05 | 3 | 143 | 2 | DOID:14261 (implicated_via_orthology) | |
| Disease | malignant pleural mesothelioma (implicated_via_orthology) | 6.97e-05 | 3 | 143 | 2 | DOID:7474 (implicated_via_orthology) | |
| Disease | hypoplastic left heart syndrome (is_implicated_in) | 6.97e-05 | 3 | 143 | 2 | DOID:9955 (is_implicated_in) | |
| Disease | Acute Promyelocytic Leukemia | 7.37e-05 | 46 | 143 | 4 | C0023487 | |
| Disease | schizophrenia, anorexia nervosa | 8.72e-05 | 48 | 143 | 4 | MONDO_0005090, MONDO_0005351 | |
| Disease | attention deficit hyperactivity disorder, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia | 1.36e-04 | 101 | 143 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, MONDO_0004985, MONDO_0005090 | |
| Disease | Angioimmunoblastic Lymphadenopathy | 1.39e-04 | 4 | 143 | 2 | C0020981 | |
| Disease | congenital heart disease (is_implicated_in) | 2.09e-04 | 24 | 143 | 3 | DOID:1682 (is_implicated_in) | |
| Disease | Pituitary-dependent Cushing's disease | 2.31e-04 | 5 | 143 | 2 | C0221406 | |
| Disease | prostate carcinoma, breast carcinoma, ovarian carcinoma | 2.99e-04 | 27 | 143 | 3 | EFO_0000305, EFO_0001075, EFO_0001663 | |
| Disease | Sezary Syndrome | 2.99e-04 | 27 | 143 | 3 | C0036920 | |
| Disease | Cushing Syndrome | 3.45e-04 | 6 | 143 | 2 | C0010481 | |
| Disease | Tetralogy of Fallot | 3.45e-04 | 6 | 143 | 2 | cv:C0039685 | |
| Disease | Leukemia, Myelomonocytic, Chronic | 3.45e-04 | 6 | 143 | 2 | C0023480 | |
| Disease | TETRALOGY OF FALLOT | 3.45e-04 | 6 | 143 | 2 | 187500 | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 6.29e-04 | 80 | 143 | 4 | DOID:12930 (implicated_via_orthology) | |
| Disease | Sudden Cardiac Death | 6.41e-04 | 8 | 143 | 2 | C0085298 | |
| Disease | Colorectal Carcinoma | TET2 FLNC ABCA3 ELOA2 RBM10 MCC GMCL2 KCNA10 TLR2 EIF4G1 CCDC93 | 6.47e-04 | 702 | 143 | 11 | C0009402 |
| Disease | myeloid white cell count | TET2 STXBP5 MCC CDH23 CHGA ITGAL USP8 MLXIPL GTF3C1 POLI PINX1 PKN2 DNMT3A | 6.59e-04 | 937 | 143 | 13 | EFO_0007988 |
| Disease | Neoplasm Recurrence, Local | 8.96e-04 | 39 | 143 | 3 | C0027643 | |
| Disease | Facies | 1.02e-03 | 10 | 143 | 2 | C0282631 | |
| Disease | Peripheral T-Cell Lymphoma | 1.02e-03 | 10 | 143 | 2 | C0079774 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 1.02e-03 | 10 | 143 | 2 | OBA_2045163 | |
| Disease | reaction time measurement | TET2 GATAD2A FBRSL1 MCC DGKZ MLXIPL FXR1 KIAA1549L UTP25 POLI | 1.43e-03 | 658 | 143 | 10 | EFO_0008393 |
| Disease | disorder of pharynx | 1.45e-03 | 46 | 143 | 3 | MONDO_0020592 | |
| Disease | primary ovarian insufficiency (implicated_via_orthology) | 1.45e-03 | 46 | 143 | 3 | DOID:5426 (implicated_via_orthology) | |
| Disease | acute myeloid leukemia (is_marker_for) | 1.74e-03 | 49 | 143 | 3 | DOID:9119 (is_marker_for) | |
| Disease | tetralogy of Fallot (is_implicated_in) | 1.76e-03 | 13 | 143 | 2 | DOID:6419 (is_implicated_in) | |
| Disease | reticulocyte measurement | SEMA4D GATAD2A MMP28 POTEF RICTOR MLXIPL BAZ1A JAG1 EIF4G1 PKN2 BSN SOAT1 DNMT3A | 1.88e-03 | 1053 | 143 | 13 | EFO_0010700 |
| Disease | Pneumoconiosis | 2.04e-03 | 14 | 143 | 2 | C0032273 | |
| Disease | Bagassosis | 2.04e-03 | 14 | 143 | 2 | C0004681 | |
| Disease | IGFBP-3 measurement | 2.31e-03 | 54 | 143 | 3 | EFO_0004626 | |
| Disease | Tetralogy of Fallot | 2.68e-03 | 16 | 143 | 2 | C0039685 | |
| Disease | coffee consumption, cups of coffee per day measurement | 2.68e-03 | 16 | 143 | 2 | EFO_0004330, EFO_0006782 | |
| Disease | Hypertrophic Cardiomyopathy | 2.69e-03 | 57 | 143 | 3 | C0007194 | |
| Disease | abdominal fat cell number | 2.84e-03 | 198 | 143 | 5 | EFO_0021534 | |
| Disease | colorectal cancer (is_implicated_in) | 2.90e-03 | 121 | 143 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | PROSTATE CANCER, HEREDITARY, 1 | 3.12e-03 | 60 | 143 | 3 | C4722327 | |
| Disease | sinusitis (is_marker_for) | 3.39e-03 | 18 | 143 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | hematocrit | CACNA1C SEMA4D FBRSL1 CHD3 NR3C1 SPATA33 CCDC47 JAG1 PKN2 BSN PADI2 DNMT3A | 3.85e-03 | 1011 | 143 | 12 | EFO_0004348 |
| Disease | hypertension | 3.93e-03 | 307 | 143 | 6 | EFO_0000537 | |
| Disease | Deaf Mutism | 4.18e-03 | 20 | 143 | 2 | C4082305 | |
| Disease | Deafness, Acquired | 4.18e-03 | 20 | 143 | 2 | C0751068 | |
| Disease | Hearing Loss, Extreme | 4.18e-03 | 20 | 143 | 2 | C0086395 | |
| Disease | Complete Hearing Loss | 4.18e-03 | 20 | 143 | 2 | C0581883 | |
| Disease | Bilateral Deafness | 4.18e-03 | 20 | 143 | 2 | C3665473 | |
| Disease | Prelingual Deafness | 4.18e-03 | 20 | 143 | 2 | C0011052 | |
| Disease | dilated cardiomyopathy | 4.18e-03 | 20 | 143 | 2 | EFO_0000407 | |
| Disease | hearing loss | 4.26e-03 | 67 | 143 | 3 | EFO_0004238 | |
| Disease | Prostate cancer, familial | 4.62e-03 | 69 | 143 | 3 | C2931456 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NLRESKQREEDDEDP | 16 | P59817 | |
| ANGEIVQDDDPRVRT | 6 | Q96D05 | |
| REPDNGKEEQERDLL | 766 | Q9HCM7 | |
| DKDLEEAGRREISPQ | 926 | A6H8Y1 | |
| NEGRAAEAEPRALEN | 131 | P55884 | |
| DVLKDRPQEADGIDS | 171 | P55884 | |
| NANIREEDEKRPAEE | 571 | Q9UJX6 | |
| ERKDDRERGEGQEPA | 141 | Q5VTR2 | |
| KRADPQQLRQEDSDA | 596 | Q9NXG0 | |
| GEEQEEPRGKEERQE | 26 | Q9Y6K1 | |
| EKQDRDGNIPDNFRE | 721 | Q86TB3 | |
| LEPAREQGSLDAERN | 61 | Q96IF1 | |
| EKNGGEPDDAELVRL | 41 | O43687 | |
| EQGEERKRELQVPEE | 321 | Q12774 | |
| EQGEERKRELQVPEE | 321 | A5YM69 | |
| LKDALQAEGQEPREV | 986 | Q99758 | |
| REERENNLPEDILGK | 816 | O14490 | |
| DNEKEREVPRGLGEQ | 661 | Q9BSW2 | |
| RQQETREVPREEGAA | 511 | Q8TF21 | |
| GDASKARLELREENP | 36 | Q6W2J9 | |
| LAKDNPGDVASNRRE | 2476 | Q9H251 | |
| TRARQDSQGEEAEPL | 1246 | A7MBM2 | |
| DSQEEEEVSLPKRGR | 1251 | Q9NRL2 | |
| LEPENREEGQERRVS | 201 | Q8TBY9 | |
| EKLNGTDPEDVIRNA | 91 | P19105 | |
| EQERGGPEREEKLTD | 741 | P98175 | |
| IGNKADLPDQREVNE | 131 | O00194 | |
| RKRSVQEGENPDDGV | 11 | P42696 | |
| GLSPEERREKQAIEE | 441 | Q01804 | |
| LKQREEQAEPDGTEE | 366 | P12883 | |
| EPEEEANGSEILAKR | 121 | P01210 | |
| ELRRQQREEEGPGDE | 306 | Q8IW93 | |
| QKRALERDPTEDDVE | 11 | Q86YP4 | |
| QEPEINKDGDRELEN | 521 | A5A3E0 | |
| GLSPEEKEQLSNDRE | 331 | Q8IYF1 | |
| AVEEKIRQEDAQGPR | 1386 | Q8WXD9 | |
| IRQEDAQGPRDSAAE | 1391 | Q8WXD9 | |
| VRVEGDNDKKNPREE | 326 | P51116 | |
| DNTEDKEDARPNREA | 266 | Q99795 | |
| EKENEGNDVPDCRRT | 351 | O15151 | |
| FKEQRDRPEAQEQSE | 196 | Q0VAK6 | |
| DGRNKPTELLEENTE | 1891 | Q13439 | |
| VRIEGDNENKLPRED | 316 | P51114 | |
| QKIRETGERPSNEEI | 291 | O95202 | |
| RPGFEKEEASQEERQ | 2351 | Q9UPA5 | |
| NEEDPEKQRRLEEAA | 446 | Q96A33 | |
| DGTRLDDQPKADVLE | 541 | Q8IVT5 | |
| TEGKPERAEAQERVA | 236 | Q96BK5 | |
| RERLQAESPEEEKGL | 961 | O75037 | |
| VEDLSRDQRKEFPND | 106 | Q9H4M3 | |
| EDDEDARKQTPKQRL | 151 | Q14315 | |
| ENLRSPEEVDKESQR | 901 | P48681 | |
| REENPSSVLAQERGD | 11 | P04150 | |
| RKRNVPASDEEEGAV | 1326 | Q6ZVL6 | |
| NEPGKGRLVREDEND | 246 | Q9Y5B6 | |
| DVDADRDGVVEKNNP | 121 | Q9Y2J8 | |
| NGNEDEEGRQKIREE | 226 | Q9BUQ8 | |
| RELDNEDRVDSKPEG | 166 | Q13316 | |
| EQKGGEEQRADRPAE | 311 | O15529 | |
| ELEKTEADNAERPRA | 121 | P52952 | |
| KRVIESGPDQLNDNE | 366 | Q9P0J1 | |
| ELVRNGDEENPLKRG | 601 | P52756 | |
| PDTAEGQLKEDREAR | 266 | Q6R327 | |
| DSASGQKNKPREERD | 1506 | Q7Z6E9 | |
| LADEQDKETVRVQGP | 26 | Q9H813 | |
| EEQEVRDDNRPKGRE | 656 | O00461 | |
| QEPEINKDGDRELEN | 521 | Q6S8J3 | |
| SREEVNEKLRDTPDG | 336 | O00459 | |
| RETENEEKQNIPGEI | 466 | Q16322 | |
| SQEELRPAQENRKED | 6 | A4FU69 | |
| QEIENLKAERAPRGD | 416 | Q567U6 | |
| DVKPRGDSQRLDLEN | 601 | P23508 | |
| GDDTNDPENRRKLKE | 586 | Q9NPB8 | |
| DDENRQLTLPEEDKR | 1946 | Q13936 | |
| RDNQDREENDKDPER | 1211 | Q14152 | |
| RDEKEALGQNEESPK | 386 | Q9H8Y5 | |
| RRGQRPKESEQDVED | 41 | Q8N8J7 | |
| GIRTPLEKEEAENQE | 1566 | Q12873 | |
| KEEPQGQLSLERDRE | 1101 | Q5SYB0 | |
| EDQERLKPEGQREHS | 431 | Q6ZU35 | |
| GQKRDEEEEATERKP | 1026 | Q6ZU35 | |
| LPDAAQNDDRSKRDG | 531 | Q4KMG0 | |
| DDEKLQRRQEKAGPS | 841 | Q8N1P7 | |
| QEPEERASLSEKERQ | 601 | Q2V2M9 | |
| EQKGGEEQRADRPAE | 311 | O14843 | |
| RQKELRAQEDPGEAL | 386 | A1A5D9 | |
| RIRDPNQGGKDITEE | 181 | Q04637 | |
| NAENKRPEEDRESGR | 431 | Q7KZI7 | |
| KENGTENLKIDRPED | 2746 | Q03164 | |
| KAERAQQPEAGEDRR | 1041 | Q76NI1 | |
| GDTPRQRAEKAQDTE | 891 | Q13574 | |
| EPRNEEEGNSEEIKA | 301 | O75844 | |
| DNRLKDERISQGPKE | 626 | Q9UNA4 | |
| KDVDQETGEDLNPNR | 336 | Q14562 | |
| RKEPGDEEEVDLIQN | 656 | Q9HC10 | |
| AEEAEKNPVGLARNE | 1916 | Q9HC10 | |
| ISAEDIRDDGNPIKE | 1016 | P78504 | |
| TDDSRLPRAEAEQEK | 126 | Q96CV9 | |
| DAQPAERGGQELRKE | 21 | Q9H239 | |
| RDEPAKAGEAAELQD | 651 | Q9NZT2 | |
| DDDDFRDQGLTRPKV | 341 | Q68CQ4 | |
| NRLSKSRENPEEDED | 11 | P35610 | |
| DQEELSRQLDRQSPG | 901 | Q24JP5 | |
| RNGEAVPEDEQISAK | 371 | O60282 | |
| LNIKEDPDGENARRA | 171 | Q9P2K5 | |
| QDREVGPQEINKEDL | 376 | Q8NEA9 | |
| KRSQEPEINKDGDRE | 481 | P0CG39 | |
| AGDPQEVKRDLEDLG | 511 | Q05823 | |
| RLKQAIEEEGGDPDN | 51 | Q9NWH9 | |
| QEPEINKDGDRELEN | 521 | P0CG38 | |
| EDSQRIDDLSARDKP | 831 | Q92854 | |
| EEGTPRDQRAQGKDI | 736 | P20701 | |
| PERRLGASEKDAEDV | 896 | Q16513 | |
| VEKLRRPEGASNESE | 361 | O75381 | |
| RNKDDRPNTDIVDED | 486 | Q5T5C0 | |
| SREDDLLAPKQAEGR | 196 | Q9NP71 | |
| NDRRNKEKAIEEGIP | 176 | Q9Y2L1 | |
| EGNPAEINVERDEKL | 591 | Q9BXP5 | |
| EEKKEEEGSANRRPE | 416 | P10645 | |
| EIEELKENQVPGDRG | 96 | O14967 | |
| PKAQELRDGENEEES | 166 | O43298 | |
| QEARQADRESEKPVD | 36 | Q96N06 | |
| EDEEQRGPELKQASR | 506 | Q7KZ85 | |
| AEDTDRPATQGELKR | 396 | A6NCW7 | |
| KREDDQGAAEIQVPD | 51 | Q96GT9 | |
| RQRQPREDGNEEDKE | 251 | P67809 | |
| APNKDVQREIADLGE | 786 | P49588 | |
| EENAEDRNPGLSKER | 236 | Q969K3 | |
| IRKQESPIREGNQEE | 106 | A0A1B0GVG6 | |
| VRPQNAEEEKRGLDL | 301 | Q92504 | |
| RLEVPKSADDRGAEE | 891 | Q5TF21 | |
| NQLDGTKEERELPRV | 191 | Q9P2N2 | |
| LLNEDDDDQPRGLTK | 536 | Q9NVW2 | |
| DDDQPRGLTKEQIDN | 541 | Q9NVW2 | |
| EADPDSRNKEEERQR | 111 | Q9BV97 | |
| EERQREGTGALEKPD | 121 | Q9BV97 | |
| REQEAKREPVGNDVA | 461 | Q9UPY6 | |
| SKRLLRNDAPEEAGE | 41 | Q96DC7 | |
| EQRKLGNAPAEVDEE | 41 | O95391 | |
| EEKGIKNDRPEDQLS | 11 | Q569K4 | |
| EDGQPRRAVDNEKEG | 386 | Q13530 | |
| EGKPALSEEERQEQT | 81 | Q04323 | |
| PQRRKKEESGADQEL | 846 | Q9P2E3 | |
| AEDTDRPATQGELKR | 396 | P0C7H9 | |
| AEDTDRPATQGELKR | 396 | P0C7I0 | |
| INEDQEESQKPRLGE | 21 | Q8TBZ6 | |
| DREDADIQREDPQAR | 1821 | Q12789 | |
| SIQLGQSEKERPEEA | 471 | Q14679 | |
| EDNREFGGKPEDEQL | 1401 | Q6N021 | |
| RASDNDRVIDPGKVE | 296 | O60603 | |
| KGDSSERERREQNLP | 216 | Q8NG27 | |
| EDTDDTERNKAQREP | 621 | P40818 | |
| EKLEDQLSEGRNSPE | 1231 | Q5VUA4 | |
| EPIGKEDLQSSRDRD | 406 | P51811 | |
| RPADRQEENKAGLLD | 666 | Q13488 | |
| DRQEEPGQLEESGEK | 176 | A6NP61 | |
| TEQNPERKVEEDGAE | 1811 | Q9P2D8 |